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ABSTRACT 
The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk 
assessments carried out by the competent authority of the rapporteur Member State France, for the pesticide 
active substance sedaxane are reported. The context of the peer review was that required by Commission 
Regulation (EU) No 188/2011. The conclusions were reached on the basis of the evaluation of the representative 
uses of sedaxane as a fungicide for seed treatment on wheat. The reliable endpoints concluded as being 
appropriate for use in regulatory risk assessment, derived from the available studies and literature in the dossier 
peer reviewed, are presented.  Missing information identified as being required by the regulatory framework is 
listed. Concerns are identified. 
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SUMMARY 
Sedaxane is a new active substance for which in accordance with Article 6(2) of Council Directive 
91/414/EEC France (hereinafter referred to as the designated rapporteur Member State (RMS)) 
received an application from Syngenta Crop Protection AG for approval. Complying with Article 6(3) 
of Directive 91/414/EEC, the completeness of the dossier was checked by the RMS.  The European 
Commission recognised in principle the completeness of the dossier by Commission Decision 
2011/123/EU of 23 February 2011. 
The RMS provided its initial evaluation of the dossier on sedaxane in the Draft Assessment Report 
(DAR), which was received by the EFSA on 10 May 2011.  The peer review was initiated on 10 June 
2011 by dispatching the DAR for consultation of the Member States and the applicant Syngenta Crop 
Protection AG.  
Following consideration of the comments received on the DAR, it was concluded that EFSA should 
conduct an expert consultation in the areas of mammalian toxicology and ecotoxicology, and should 
adopt a conclusion on whether sedaxane can be expected to meet the conditions provided for in Article 
5 of Directive 91/414/EEC, in accordance with Article 8 of Commission Regulation (EU) No 
188/2011. 
The conclusions laid down in this report were reached on the basis of the evaluation of the 
representative use of sedaxane as a fungicide for seed treatment on wheat, as proposed by the 
applicant. Full details of the representative uses can be found in Appendix A to this report. 
No data gaps or areas of concern were identified in the section on identity, physical/chemical/technical 
properties and methods of analysis.  
No data gaps or areas of concern were identified in the mammalian toxicology section. 
No data gaps or areas of concern were identified in the residue section. 
The fate and behaviour of sedaxane in the environment was investigated with a complete set of 
studies, however a data gap was identified for a groundwater exposure assessment for the minor non-
transient metabolite CSCD728931. No information has been provided on the environmental behaviour 
of each individual enantiomer of this metabolite, which contains one chiral carbon atom. It is not 
known if one isomer is degraded more quickly than the other or if any other conversion between 
isomers occurs. 
On the basis of the available data, a high long-term risk was identified for granivorous birds and 
mammals.  The acute and long-term risk to birds and mammals from other routes of exposure was 
concluded to be low.  A low risk to aquatic organisms, bees, non-target arthropods, earthworms, soil 
micro-organisms, soil macro-organisms, non-target plants and sewage treatment organisms was 
concluded.   
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BACKGROUND 
In accordance with Article 80(1)(a) of Regulation (EC) No 1107/2009,
3 Council Directive 
91/414/EEC
4 continues to apply with respect to the procedure and conditions for approval for active 
substances for which a decision recognising in principle the completeness of the dossier was adopted 
in accordance with Article 6(3) of that Directive before 14 June 2011. 
Commission Regulation (EU) No 188/2011
5 (hereinafter referred to as ‘the Regulation’) lays down the 
detailed rules for the implementation of Council Directive 91/414/EEC as regards the procedure for 
the assessment of active substances which were not on the market on 26 July 1993.  This regulates for 
the European Food Safety Authority (EFSA) the procedure for organising the consultation of Member 
States and the applicant for comments on the initial evaluation in the Draft Assessment Report (DAR) 
provided by the rapporteur Member State (RMS), and the organisation of an expert consultation, 
where appropriate.   
In accordance with Article 8 of the Regulation, EFSA is required to adopt a conclusion on whether the 
active substance is expected to meet the conditions provided for in Article 5 of Directive 91/414/EEC 
within 4 months from the end of the period provided for the submission of written comments, subject 
to an extension of 2 months where an expert consultation is necessary, and a further extension of upto 
8 months where additional information is required to be submitted by the applicant in accordance with 
Article 8(3).  
In accordance with Article 6(2) of Council Directive 91/414/EEC France (hereinafter referred to as the 
designated rapporteur Member State (RMS)) received an application from Syngenta Crop Protection 
AG for approval of the active substance sedaxane. Complying with Article 6(3) of Directive 
91/414/EEC the completeness of the dossier was checked by the RMS.  The European Commission 
recognised in principle the completeness of the dossier by Commission Decision 2011/123/EU of 23 
February 2011
6. 
The RMS provided its initial evaluation of the dossier on sedaxane in the DAR, which was received 
by the EFSA on 10 May 2011 (France, 2011). The peer review was initiated on 10 June 2011 by 
dispatching the DAR to Member States and the applicant Syngenta Crop Protection AG for 
consultation and comments. In addition, the EFSA conducted a public consultation on the DAR. The 
comments received were collated by the EFSA and forwarded to the RMS for compilation and 
evaluation in the format of a Reporting Table.  The applicant was invited to respond to the comments 
in column 3 of the Reporting Table. The comments and the applicant’s response were evaluated by the 
RMS in column 3. 
The need for expert consultation and the necessity for additional information to be submitted by the 
applicant in accordance with Article 8(3) of the Regulation were considered in a telephone conference 
between the EFSA, the RMS, and the European Commission on 28 September 2011. On the basis of 
the comments received, the applicant’s response to the comments and the RMS’s evaluation thereof, it 
was concluded that additional information should be requested from the applicant, and that the EFSA 
should organise an expert consultation in the areas of mammalian toxicology and ecotoxicology. 
                                                      
3 Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing 
of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. OJ No L 309, 
24.11.2009, p. 1-50. 
4 Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market. OJ L 
230, 19.8.1991, p. 1-32, as last amended.  
5 Commission Regulation (EU) No 188/2011 of 25 February 2011 laying down detailed rules for the implementation of 
Council Directive 91/414/EEC as regards the procedure for the assessment of active substances which were not on the 
market 2 years after the date of notification of that Directive. OJ No L 53, 26.2.2011, p. 51-55. 
6  Commission Decision 2011/123/EC of 23 February 2011 recognising in principle the completeness of the dossiers 
submitted for detailed examination in view of the possible inclusion of sedaxane and Bacillus firmus I-1582 in Annex I to 
Council Directive 91/414/EEC. OJ No L 49, 24.2.2011, p. 40-41. Peer Review of the pesticide risk assessment of the active substance sedaxane
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The outcome of the telephone conference, together with EFSA’s further consideration of the 
comments is reflected in the conclusions set out in column 4 of the Reporting Table. All points that 
were identified as unresolved at the end of the comment evaluation phase and which required further 
consideration, including those issues to be considered in an expert consultation, and the additional 
information to be submitted by the applicant, were compiled by the EFSA in the format of an 
Evaluation Table. 
The conclusions arising from the consideration by the EFSA, and as appropriate by the RMS, of the 
points identified in the Evaluation Table, together with the outcome of the expert discussions where 
these took place, were reported in the final column of the Evaluation Table. 
A final consultation on the conclusions arising from the peer review of the risk assessment took place 
with Member States via a written procedure in June 2012. 
This conclusion report summarises the outcome of the peer review of the risk assessment on the active 
substance and the representative formulation evaluated on the basis of the representative use as a 
fungicide for seed treatment on wheat, as proposed by the applicant. A list of the relevant end points 
for the active substance as well as the formulation is provided in Appendix A. In addition, a key 
supporting document to this conclusion is the Peer Review Report, which is a compilation of the 
documentation developed to evaluate and address all issues raised in the peer review, from the initial 
commenting phase to the conclusion. The Peer Review Report (EFSA, 2012) comprises the following 
documents, in which all views expressed during the course of the peer review, including minority 
views, can be found: 
•  the comments received on the DAR, 
•  the Reporting Table (29 September 2011),  
•  the Evaluation Table (2 July 2012), 
•  the reports of the scientific consultation with Member State experts, where relevant, 
•  the comments received on the assessment of the additional information, 
•  the comments received on the draft EFSA conclusion. 
Given the importance of the DAR including its addendum (compiled version of June 2012 containing 
all individually submitted addenda (France, 2012)) and the Peer Review Report, both documents are 
considered respectively as background documents A and B to this conclusion.  Peer Review of the pesticide risk assessment of the active substance sedaxane
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THE ACTIVE SUBSTANCE AND THE FORMULATED PRODUCT 
Sedaxane is the ISO common name for a mixture of 2 cis-isomers 2’-[(1RS,2RS)-1,1’-bicycloprop-2-
yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxanilide and 2 trans-isomers 2’-[(1RS,2SR)-1,1’-
bicycloprop-2-yl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxanilide (IUPAC). 
The representative formulated product for the evaluation was ‘A16148C’ a flowable concentrate for 
seed treatment (FS ) containing 500 g/L sedaxane. 
The representative use evaluated comprises field use seed treatment against Microdochium nivale in 
wheat. Full details of the GAP can be found in the list of end points in Appendix A.  
CONCLUSIONS OF THE EVALUATION 
1.  Identity, physical/chemical/technical properties and methods of analysis 
The following guidance documents were followed in the production of this conclusion: 
SANCO/3030/99 rev.4 (European Commission, 2000) and SANCO/825/00 rev. 7 (European 
Commission, 2004a). 
The minimum purity of sedaxane is 960 g/kg (range 820-890 g/kg for the 2 trans-isomers 
(SYN508210 - 50:50 mixture of enantiomers), and range 100-150 g/kg for the 2 cis-isomers 
(SYN508211 - 50:50 mixture of enantiomers)). The specification is based on the analysis of full scale 
production batches. There are no relevant impurities and no FAO specification.  
The assessment of the data package revealed no issues that need to be included as critical areas of 
concern with respect to the identity, physical, chemical and technical properties of sedaxane or the 
representative formulation. It should be noted that the persistent foam of the representative 
formulation after 1 minute is higher than the acceptable limit. The main data regarding the identity of 
sedaxane and its physical and chemical properties are given in Appendix A. 
Adequate analytical methods are available for the determination of sedaxane in the technical material 
and in the representative formulation as well as for the determination of the respective impurities in 
the technical material. 
The methods of analysis for products of plant origin are by HPLC-MS/MS. Methods of analysis for 
products of animal origin are not required as no MRLs are proposed. However, such methods for the 
determination of residues of parent compound as well as for CSCD658906 and CSCD659087 
metabolites have been provided and are considered acceptable. The applicability of multi-residue 
method (QuEChERS) for sedaxane in plant matrices and food of animal origin have been 
demonstrated by acceptable validation. Soil, water and air are analysed by HPLC-MS/MS. A method 
of analysis for body fluids and tissues is not required as the active substance is not classified as toxic 
or very toxic.  
2.  Mammalian toxicity 
The following guidance documents were followed in the production of this conclusion: 
SANCO/221/2000 rev. 10 - final (European Commission, 2003), SANCO/222/2000 rev. 7 (European 
Commission, 2004b) and SANCO/10597/2003 – rev. 8.1 (European Commission, 2009). 
Sedaxane was discussed at the Pesticides Peer Review Meeting 90 in April 2012.  Peer Review of the pesticide risk assessment of the active substance sedaxane
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The batches used in the toxicological studies support the technical specification as presented for the 
full scale production. No impurity was found to be relevant in the technical specification. The 
toxicological studies were performed with a ratio of trans-:cis-isomers of 83.1:11.9. Based on a 28-
day comparative dietary study performed with sedaxane trans-isomers, cis-isomers and a 1:1 mixture 
of these two isomers in rats, similar toxicity was attributed to all three test materials. No toxicological 
information was available on the relative toxicity of the two enantiomers present in the trans- and cis-
isomers. 
Low acute toxicity has been observed when sedaxane was administered by the oral, dermal and 
inhalation routes. No skin or eye irritation was observed and no potential for skin sensitisation was 
reported in a Local Lymph Node Assay (LLNA). 
The main target organ of sedaxane upon short-term and long-term exposure was the liver with 
increased weight and centrilobular hypertrophy in rats, the most sensitive species tested. Liver 
biochemistry measurements indicated the involvement of enzyme induction with marked CYP2B and 
CYP3A induction in rats. The relevant short-term NOAEL was 28 mg/kg bw per day from the 90-day 
study in rats and the relevant long-term NOAEL was 11 mg/kg bw per day from the 2-year study in 
rats. No carcinogenic effect was observed in rats up to 218 mg/kg bw per day. In mice effects on the 
liver appeared at much higher dose levels than in rats; in male mice an increased incidence of liver 
tumours was observed, slightly above the historical control range at the highest dose level, which was 
considered not relevant to humans. No classification was proposed regarding carcinogenicity, but the 
final decision should be taken under Regulation (EC) No 1272/2008
7. No genotoxic potential is 
attributed to sedaxane. 
In a reproductive toxicity study in rats some effects were observed that could indicate a hormonal 
involvement at the high dose level of 104 mg/kg bw per day, such as increased ano-genital distance in 
female offspring, no mechanistic study was available to confirm this. Fertility and reproduction 
remained unaffected and therefore the reproductive NOAEL was set at the highest dose tested; 
parental and offspring NOAELs were set at the mid-dose of 35 mg/kg bw per day, based on reduced 
body weight, body weight gain and liver effects appearing at the higher dose level. No developmental 
effect was observed in rats or rabbits, decreased foetal weight was attributed to maternal toxicity. 
No evidence of neurotoxicity was seen in acute and short-term neurotoxicity studies. The NOAEL for 
general toxicity in the acute neurotoxicity study was 30 mg/kg bw, based on reduced locomotor 
activity, and decreased body weight and body weight gain at the higher dose level. 
Toxicological studies were provided on two metabolites found in groundwater at levels exceeding 0.1 
µg/L according to environmental fate and behaviour models (see section 4). Metabolite CSAA798670 
presented low acute oral toxicity and short-term toxicity, no adverse effects were observed up to 1007 
mg/kg bw per day (limit dose) in a 28-day dietary study in rats. No genotoxic potential was observed 
in three in vitro studies. The metabolite was non-relevant from the toxicological point of view 
according to the guidance document on the assessment of groundwater metabolites (European 
Commission, 2003). 
Metabolite CSCD465008 exceeded 0.75 µg/L in all 9 scenarios and was not found in rat metabolism 
studies performed with sedaxane. It presented low acute oral toxicity and short-term toxicity, no 
adverse effects were observed up to 1018 mg/kg bw per day (limit dose) in a 28-day dietary study in 
rats. No genotoxic potential has been observed in three in vitro studies. The metabolite was non-
relevant from the toxicological point of view according to the guidance document on the assessment of 
groundwater metabolites (European Commission, 2003). As a consumer risk assessment is required 
for drinking water, an acceptable daily intake (ADI) is needed. This metabolite is common to other 
                                                      
7 Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, 
labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and 
amending Regulation (EC) No 1907/2006.  OJ L 353, 31.12.2008, p. 1-1355. Peer Review of the pesticide risk assessment of the active substance sedaxane
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pyrazole active substances. As a more critical NOAEL was presented in two other dossiers 
(fluxapyroxad and isopyrazam) in a rabbit developmental toxicity study, this study was also taken into 
consideration to derive the ADI of CSCD465008. In this study, no adverse effect was observed on the 
development of foetuses up to 1000 mg/kg bw per day (limit dose), the maternal NOAEL was 300 
mg/kg bw per day based on reduction of maternal body weight, decreased food intake and increased 
abortion incidence at the highest dose level. The ADI of CSCD465008 is 0.3 mg/kg bw per day, based 
on the NOAEL of 300 mg/kg bw per day from the developmental toxicity study in rabbits, with an 
assessment factor (AF) of 1000 applied to account for the limited database available (no long-term, 
multigeneration or rat developmental toxicity study available). 
Pending on the assessment of the levels of metabolite CSCD728931 in groundwater, a toxicological 
assessment may be required (see data gap in section 4). 
The ADI of sedaxane is 0.11 mg/kg bw per day, based on the NOAEL of 11 mg/kg bw per day from 
the 2-year rat study, applying the standard AF of 100. The acceptable operator exposure level (AOEL) 
is 0.28 mg/kg bw per day, based on the NOAEL of 28 mg/kg bw per day from the 90-day rat study, 
applying a 100 AF, and no correction regarding oral absorption being required. The acute reference 
dose (ARfD) is 0.3 mg/kg bw, based on the NOAEL of 30 mg/kg bw from the acute neurotoxicity 
study in rats, and applying 100 AF. 
The estimated operator exposure level is below the AOEL when no personal protective equipment 
(PPE) is considered, according to the French seed Tropex model. Worker exposure according to the 
same model, which assumes the use of long-sleeved work jacket and long trousers, represented 1.6% 
of the AOEL. It is noted that the relative toxicity and possible preferential metabolism/degradation of 
the enantiomers present in the cis- and trans- isomers in animals, plants and the environment was not 
investigated, however considering the high margin between worker exposure and the AOEL, it is 
considered unlikely that the AOEL would be exceeded even if a complete shift would occur after 
application to a potentially more toxic enantiomer. Bystander exposure is not relevant to the 
representative use in industrial seed treatment facilities. 
3.  Residues 
The assessment in the residue section below is based on the guidance documents listed in the 
document 1607/VI/97 rev.2 (European Commission, 1999), and the JMPR recommendations on 
livestock burden calculations stated in the 2004 and 2007 JMPR reports (JMPR 2004, JMPR 2007). 
Sedaxane is a mixture of two enantiomeric pairs of trans- (SYN508210) and cis- (SYN508211) 
isomers. The methods of analysis used in the residue section were able to distinguish trans- isomer 
from cis- isomer but the methods were not enantioselective and therefore no information was provided 
on the behaviour of the individual enantiomers. The residues reported as the trans- or cis-sedaxane are 
for the sum of enantiomers. It is also not known whether one enantiomer is degraded preferentially to 
the other in plant and animal matrices. 
The metabolism of sedaxane was investigated in spring wheat (cereals), soybean (pulses and oilseeds) 
and Swiss chard (leafy crops) as a seed treatment, with sedaxane 
14C-labelled in the phenyl and the 
pyrazole rings with a ratio of trans- and cis-isomers of 6:1, which is compliant with the agreed 
specification of the active substance. The metabolism study on spring wheat was performed in 
compliance with the representative use (4N rate). The total radioactive residues (TRR) in wheat grain 
at harvest were recovered at a trace level (0.004-0.008 mg equiv./kg) and no further metabolite 
investigation was attempted. Sedaxane (sum of isomers) was found to be a major compound in wheat 
foliage and straw (up to 18% TRR) and in Swiss chard leaves (up to 52% TRR) while it was not 
detected in soybean seeds, where the predominant metabolite was CSCD465008 (N-desmethyl 
pyrazole acid) in its free and conjugated forms (30% TRR). All of the other identified metabolites in 
all crops were present in much lower proportions and concentrations. The metabolic pathway of Peer Review of the pesticide risk assessment of the active substance sedaxane
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sedaxane was similar in the three crop groups involving different routes of degradation as N-
demethylation of the pyrazole ring, hydroxylation of the phenyl and cyclopropyl rings, opening of the 
cyclopropyl ring and the amide bond cleavage between the phenyl and pyrazole rings. Metabolism of 
sedaxane was also studied in succeeding crops, such as wheat, radish/turnip and lettuce and was 
characterized by a preferential cleavage of the amide bond linkage of the parent molecule. The 
predominant metabolites that were detected in all parts of the rotational crops but mainly in leafy crops 
were CSAA798670 (pyrazole acid) and CSCD465008 (N-desmethyl pyrazole acid). Since these 
metabolites are major soil metabolites it is suggested that a potential uptake from the soil may also 
occur. Sedaxane was found to be hydrolytically stable under the representative conditions of 
processing such as pasteurisation, baking/brewing/boiling and sterilisation.  
Based on the metabolic pathway in primary and rotational crops, the plant residue definition for 
monitoring and risk assessment is proposed as parent sedaxane (sum of isomers) for all categories of 
crops and is restricted to seed and soil treatments.  
A sufficient number of residue trials conducted in wheat in Northern and Southern Europe were 
provided. In grain, residue levels were all below the LOQ value, and therefore a MRL of 0.01 mg/kg 
was proposed for wheat grain. Rotational crop residue trials conducted on carrot/radish, spinach and 
wheat/barley at a dose rate close to the calculated plateau concentration of sedaxane in soil (0.9 N) 
indicated that the residues in all edible parts of rotated crops were below the LOQ (<0.01 mg/kg) of 
the analytical method with regard to the sum of trans-and cis-sedaxane, and the pertinent metabolites 
CSAA798670 and CSCD465008, which were therefore disregarded for potential inclusion in the 
residue definition for risk assessment in plant matrices. It was concluded that the residue definitions 
for monitoring and risk assessment set for the primary crops also apply to the rotational crops, and 
MRLs on rotational crops are not necessary. Studies on the effect of processing on the magnitude of 
the residues demonstrated that the residues of sedaxane and its metabolites remained below the LOQ 
of the method (0.01 mg/kg) in cereal processed commodities. Storage stability data provided on both 
the trans- and cis-sedaxane and several metabolites in different plant commodities covered the storage 
time interval of the residue samples from the residue trials on wheat, the rotational crop field trials and 
the processed commodities. 
Animal metabolism was studied in lactating goats and poultry with 
14C-labelled sedaxane on the 
phenyl and pyrazole rings although data were not triggered based on the dietary intake. A cow feeding 
study was also reported in the Draft Assessment Report. The metabolism data were considered as valid 
and showed an extensive degradation of the parent sedaxane into numerous metabolites that occurred 
at a trace level (<0.01 mg/kg) at the calculated dietary burden. Based on the metabolism depicted in 
poultry and ruminant matrices and the feeding study on lactating cows, the residue definition for 
monitoring and risk assessment in tissues, milk and eggs is proposed as parent sedaxane (sum of 
isomers).  Particular attention should be given to metabolite CSCD658906 free and conjugated that 
was recovered at a high proportion in liver (37% TRR), kidney (44% TRR) and in egg yolk (32% 
TRR) and to metabolite CSCD 659087 in milk (19% TRR) if in the future additional uses that are used 
as feed items are proposed.  No MRLs are proposed for livestock matrices based on the representative 
use. 
A consumer dietary risk assessment considering the proposed MRL on wheat and using the EFSA 
PRIMo model indicated a negligible chronic and acute intake for all consumer groups (TMDI <1% 
ADI and IESTI <1 % ARfD). A slight cis- to trans- isomerisation (10:1) was observed in Swiss chard 
and radish root but has no impact on the risk assessment for the representative use in view of the large 
margin of consumer safety. 
It is also noted that the non-toxicologically relevant metabolites CSCD465008 and CSAA798670 may 
leach to groundwater at significant levels (refer to section 4). The 0.1 µg/L trigger was exceeded with 
a maximum concentration of 6.371 and 0.318 µg/L, respectively as estimated for the FOCUS Pelmo 
3.3.2/Jokioinen winter cereals scenario. Therefore, an additional exposure of the consumers can be Peer Review of the pesticide risk assessment of the active substance sedaxane
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expected when groundwater is used as drinking water, although this route of exposure is not 
considered as significant (<1% ADI and ARfD). 
MRL application according to Commission Regulation (EU) No 188/2011 (Article 3(1)(g)) 
Besides the use on wheat as a seed treatment supported in the framework of the approval under 
Regulation (EC) No 1107/2009, MRLs were also requested on cereals (barley, oat, rye, triticale) in 
Northern and Southern Europe and import tolerances on soybean (North America, Canada and Brazil) 
and rapeseed (canola) (North America, Canada). EFSA evaluated the RMS assessment of the residue 
data package submitted for the requested MRLs and import tolerances. 
The additional uses as a seed treatment on soybean and rapeseed are covered by the metabolism study 
conducted on the pulses/oilseeds crop group. 
Extrapolation from wheat to barley, oat, rye and triticale was possible from the available EU residue 
database on wheat and a MRL of 0.01 mg/kg was proposed for cereals (wheat, barley, oat, rye and 
triticale). Residue trials conducted on soybean in North America and Brazil, and on rapeseed (canola) 
in North America and Canada were also submitted in the framework of the MRL application. 
Sufficient GAP compliant residue trials were provided on soybean and rapeseed seeds to support a 
MRL of 0.01 mg/kg for the requested import tolerances on soybean and rapeseed. Storage stability 
data provided on trans- and cis- isomers of sedaxane and its different metabolites covered the storage 
time interval of the residue samples from the trials on soybean and rapeseed. The analytical methods 
used for the determination of the residues of trans- and cis- isomers of sedaxane and its metabolites 
were sufficiently validated in high water, high oil, and high acid content matrices and dry commodities 
at a LOQ of 0.005 mg/kg for each sedaxane isomer and at 0.01 mg/kg for each metabolite. 
Considering these additional uses, the intakes by animals remain far below the trigger value of 0.1 
mg/kg diet (DM) and therefore, the setting of MRLs for products of animal origin was still considered 
unnecessary. 
Although the authorisation status for soybean in Brazil was not yet confirmed, EFSA recommends that 
the proposed MRLs on soybean and rapeseed seeds should be included in Annex III of Regulation 
(EC) No. 396/2005
8 as the GAPs registered on soybean in North America and Canada also lead to a no 
residue situation for sedaxane (sum of isomers) (below the LOQ of 0.01 mg/kg). 
Taking into account the proposed MRL of 0.01 mg/kg for cereals and for soybean and rapeseed seeds 
and using the EFSA PRIMo model, no chronic or acute risk was identified for consumers, the highest 
TMDI and highest IESTI remaining below 1% of the ADI and ARfD respectively. 
4.  Environmental fate and behaviour 
The fate and behaviour of sedaxane in soils under aerobic conditions was investigated using both 
14C-
phenyl labelled and 
14C-pyrazole labelled test substance. The route of degradation under laboratory 
conditions was investigated in seven soils using both direct applications to bare soil and as seed 
applied treatments. Two major (> 10% applied radioactivity (AR)) metabolites CSAA798670 
(pyrazole acid) and CSCD465008 (N-desmethyl pyrazole acid) were identified. Metabolite 
CSCD465008, was measured in seed treated soil at levels up to 31.9% AR and metabolite 
CSAA798670 was measured at levels up to 6.1% AR in seed treated soil and 14.5% AR in soil treated 
directly. Metabolite CSCD728931was measured at levels > 5% AR in four consecutive sampling 
points (5.2-6.3% AR) in one soil treated directly with 
14C-pyrazole labelled sedaxane. The peer review 
(refer to data requirement 4.3 in the Evaluation Table) considered that this metabolite requires further 
                                                      
8 Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue 
levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC.  OJ L 70, 
16.3.2005, p.1. Peer Review of the pesticide risk assessment of the active substance sedaxane
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consideration with respect to groundwater contamination and a data gap for groundwater exposure 
assessment for the minor non-transient metabolite CSCD728931 was identified. This metabolite 
contains one chiral carbon atom but no separation of the isomers was performed in the soil metabolism 
studies. Therefore, a data gap was also identified for information on the environmental behaviour of 
each individual enantiomer of metabolite CSCD728931 in soil. It is not known if one enantiomer is 
degraded more quickly than the other or if any other conversion between isomers occurs. Levels of 
radioactivity associated with carbon dioxide accounted for 0.6-20.1% AR after 122-123 days, 
increasing to 25.4 and 22.7% AR over the 1 year study duration for the 
14C-phenyl and 
14C-pyrazole 
labels respectively. Maximum levels of unextractable radioactivity after one year were 58% AR from 
both phenyl and pyrazole labelled sedaxane laboratory soil degradation studies. In all studies the 
change in the sedaxane trans:cis isomer ratio was insignificant. Although the degradation pathway 
from seed applied and bare soil applications is the same, the rate of parent degradation is faster in the 
former case, exhibiting moderate to medium persistence. As seed treatment is the only representative 
use evaluated in this conclusion, only degradation rates derived from seed applied studies have been 
used for the risk assessment endpoints for sedaxane. 
The rate of degradation of the major metabolites CSAA798670 and CSCD465008 was also 
investigated in three separate studies: one study where the precursor (minor) metabolite CSCC210616 
was applied, and the other two studies where the two major metabolites were applied as parent 
compounds. Metabolite CSAA798670 may be considered to exhibit low to moderate persistence in 
soil, while metabolite CSCD465008 may be considered to exhibit moderate to high persistence in soil 
under aerobic conditions in laboratory experiments. 
The applicant submitted a study to investigate the degradation of sedaxane in soil under anaerobic 
conditions with the substance labelled only in the phenyl ring. Under anaerobic conditions no 
metabolites ≥ 0.5% of applied 
14C-sedaxane were measured in soil. Mineralisation to carbon dioxide 
was low (<5%) and unextractable residues were <30.6%. 
Two studies were performed to assess soil photolysis. Sedaxane degraded gradually in moist and dry 
soils under irradiated conditions but in both cases more rapidly than in the corresponding dark 
controls. Up to seven minor degradation products were seen in the soil extracts from irradiated 
samples but no unique photodegradation products were detected at a significant level (no individual 
component reached 5% AR).  
The dissipation of sedaxane under field conditions was investigated in four locations in Europe. In 
these trials the samples were also analysed for the soil metabolites CSCC210616, CSAA798670 and 
CSCD465008. Sedaxane was applied to winter or spring wheat seeds as a seed treatment. Based on the 
information reported in the original study reports, the application rates in all the field trials was lower 
(range 9.9-16 g a.s./ha) than the dose (25 g a.s./ha) indicated in the GAP table and therefore it can be 
concluded that these field trials might be considered as not suitable to provide accurate information on 
the soil degradation products formed under field conditions (refer to open point 4.14 in the Evaluation 
Table). This applies also to the two soil accumulation studies, where the application rates were 6.7 and 
18.04 g a.s./ha. The dissipation half-lives normalised to the standard references conditions (20°C and 
pF2 soil moisture) ranged between 54-188 days. Field data confirmed that there was no significant 
difference in the rate of degradation of the isomeric forms of sedaxane in soil. PECsoil, including 
accumulated PEC over repeated yearly applications, were calculated for sedaxane on the basis of the 
longest estimated non-normalised soil DT50 obtained under field conditions (438 days based on SFO 
kinetics). New PEC soil for metabolite CSAA798670 has been calculated by EFSA based on the 
maximum occurrence of 14.5% in soil laboratory study. 
Sedaxane can be classified as having low to medium mobility in soil. Metabolites CSAA798670 and 
CSCD465008 are expected to be very highly mobile. 
Sedaxane is stable to hydrolysis under acidic, neutral and alkaline conditions, however, it degrades by 
direct photolysis to form metabolite CSAA798670 up to 12% AR. In sterile natural water, sedaxane Peer Review of the pesticide risk assessment of the active substance sedaxane
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degrades by indirect photolysis to form metabolites CSAA798670 (max 26% AR), CSCD668095 
(max 16% AR) and CSCD668094 (max 15% AR). Sedaxane was found to be not readily 
biodegradable in a standard biodegradability study. Degradation/dissipation in natural aqueous 
systems was investigated in two aerobic dark water/sediment studies. Sedaxane partitioned to the 
sediment relatively rapidly. Relatively low degradation occurred during the course of the experiment, 
resulting in calculated total system DegT50 = 847-885 days. Fifteen minor degradation products were 
found reaching a maximum level of 1.0% AR in the total phase of aerobic pond system. 
PECsw/sed were calculated with FOCUS SW scheme with Steps 1-2 for sedaxane, for soil metabolites 
CSAA798670 and CSCD465008, and for the two aqueous photolysis metabolites CSCD668095 and 
CSCD668094. New PECsw for metabolite CSAA798670 has been calculated by EFSA based on the 
maximum occurrence of 14.5% in soil. 
Potential groundwater contamination resulting from the application of sedaxane according to the 
representative use in cereals was assessed by calculation of 20 year 80
th percentile leachate 
concentration of sedaxane and its two major soil metabolites CSAA798670 and CSCD465008 at 1 m 
depth with FOCUS GW models and scenarios (PEARL and PELMO)(FOCUS 2000, EFSA 2004). 
Sedaxane does not exceed the limit of 0.1 µg/L for any of the scenarios simulated. For metabolite 
CSAA798670, the 0.1 µg/L limit was exceeded in 4 out of the 9 scenarios simulated with FOCUS 
PELMO for winter cereals (maximum 0.318 µg/L for Jokioinen scenario). Metabolite CSCD465008 
exceeds 0.75 µg/L in all the pertinent scenarios with both models for spring and winter cereals, with a 
maximum of 6.371 µg/L for Jokioinen scenario (PELMO simulation). According to the available 
information provided in the mammalian toxicology section, metabolite CSCD465008 should be 
regarded as not relevant. A data gap for a groundwater exposure assessment for the minor non-
transient metabolite CSCD728931 was identified. 
Sedaxane will be applied as a seed treatment and therefore volatility from soil is of no concern as the 
seed will be drilled below the soil surface. The calculation of half-life for the reaction of the active 
substance in the gas phase in the troposphere was made using the Atkinson calculation and resulted to 
be 5.1 hours. This value is under the trigger of 2 days established to represent a concern for a potential 
long-range transport by the Stockholm Convention. 
5.  Ecotoxicology 
The risk assessment was based on the following documents: European Commission (2002a, 2002b), 
SETAC (2001), and EFSA (2009). 
A low acute risk to granivorous birds and mammals was concluded on the basis of the first tier risk 
assessment presented in the DAR.  The acute and long-term risk to herbivorous birds and mammals, 
for both sedaxane and its plant metabolites, from the consumption of germinating seedlings was also 
concluded to be low.  The risk assessment for earthworm-eating and fish-eating birds and mammals 
also indicated a low risk.  The risk to birds and mammals via the consumption of contaminated water 
was assessed as low.   
The first tier long-term risk assessment for both granivorous birds and granivorous mammals indicated 
the need for a higher tier risk assessment.  A refined avian risk assessment was presented in the revised 
DAR, which considered the risk to a small granivorous bird and a medium omnivorous bird taking 
treated seed.  The refined risk assessment for a small granivorous bird, such as the linnet, was not 
considered to be sufficient to conclude a low risk. The assessment also considered a medium 
omnivorous bird, skylark, however, the refined parameters were also not considered to be sufficiently 
supported.  Therefore, on the basis of the available data, a high long-term risk to birds from 
consumption of treated seed was identified. Peer Review of the pesticide risk assessment of the active substance sedaxane
 
EFSA Journal 2012;10(7):2823    13
A refined long-term risk assessment for a small granivorous mammal was also included in the revised 
DAR. The study was used to define the proposed focal species (wood mouse) and the dietary 
components were not presented in sufficient detail for a clear, transparent risk assessment.  Therefore, 
on the basis of the available data, a high long-term risk to granivorous mammals was identified.  
 
A low risk to aquatic organisms was concluded for both sedaxane and its metabolites (CSCD668094, 
CSCD668095, CSAA798670 and CSCD465008). 
 
The representative use of sedaxane is as a seed treatment to wheat, however, since sedaxane has 
systemic properties a risk assessment for bees was presented.  On the basis of low toxicity, a low risk 
to bees could be concluded.  The risk to soil-dwelling non-target arthropods was assessed as low on 
the basis of low toxicity at exposure levels (in the toxicity studies) which exceed the soil PEC values. 
A low acute risk to earthworms from both sedaxane and soil metabolites CSCD465008 and 
CSAA798670 was concluded based on the first tier risk assessment.  The chronic earthworm toxicity 
endpoints were discussed at the Pesticides Peer Review Meeting 91 (April, 2012).  The studies 
indicated potential effects at levels less than the NOEC, selected by the study authors, based on 
statistically significant effects.  Therefore, the experts considered that the use of EC10 values would be 
more appropriate in this case.  It was acknowledged that it is not standard practice to use an EC10 value 
rather than a NOEC value for a chronic earthworm risk assessment, however, given the margin of 
safety obtained by the risk assessment the experts considered that the TER values determined using 
the EC10 values were sufficient to indicate a low risk from both sedaxane and soil metabolite 
CSCD465008.  A low risk to earthworms from soil metabolite CSAA798670 was also concluded. 
A low risk to soil micro-organisms and soil macro-organisms was also concluded for sedaxane and 
soil metabolites CSCD465008 and CSAA798670.   
Due to negligible exposure for the representative use as a seed treatment a low risk to non-target plants 
and sewage treatment organisms was also concluded.  Peer Review of the pesticide risk assessment of the active substance sedaxane
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6.  Overview of the risk assessment of compounds listed in residue definitions triggering assessment of effects data for the environmental 
compartments 
6.1.  Soil 
Compound 
(name and/or code)  Persistence Ecotoxicology 
sedaxane  moderate to medium ( DT50lab = 28.2– 69 d) 
Low risk identified.  
Lowest endpoint driving risk assessment for soil-
dwelling organisms for sedaxane: Chronic earthworm 
EC10CORR = 1.4 mg a.s./kg soil (regulatory concentration 
including a safety factor of 5 = 0.28 mg a.s./kg soil).   
The risk to soil-dwelling organisms was assessed as 
low. 
CSAA798670  low to moderate ( DT50lab = 3.2– 18 d) 
Low risk identified. 
No toxicity data for soil-dwelling organisms was 
available for this metabolite and therefore the risk 
assessment assumed that the metabolite was 10 times 
more toxic that the parent: Chronic earthworm EC10CORR 
= 0.14 mg a.s./kg soil (regulatory concentration 
including a safety factor of 5 = 0.028 mg a.s./kg soil).   
The risk to soil-dwelling organisms was assessed as 
low. Peer Review of the pesticide risk assessment of the active substance sedaxane
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CSCD465008  moderate to high ( DT50lab = 40.1– 190 d) 
Low risk identified. 
Lowest endpoint driving risk assessment for soil-
dwelling organisms for this metabolite: Chronic 
earthworm EC10 = 34 mg/kg soil (regulatory 
concentration including a safety factor of 5 = 6.8 mg/kg 
soil).   The risk to soil-dwelling organisms was assessed 
as low. 
   
 
6.2.  Ground water 
Compound 
(name and/or code)  Mobility in soil 
>0.1  μg/L 1m depth for 
the representative uses
(at least one FOCUS 
scenario or relevant 
lysimeter) 
Pesticidal activity  Toxicological relevance  Ecotoxicological activity 
sedaxane  low to medium 
(KFoc = 262-666 mL/g)  FOCUS: no  Yes  Yes 
Low risk identified. 
Lowest endpoint driving 
the aquatic risk 
assessment for sedaxane: 
fish chronic NOEC = 165 
µg/L (regulatory 
concentration including a 
safety factor of 10 = 16.5 
µg a.s./L). The risk to 
aquatic organisms was 
assessed as low. Peer Review of the pesticide risk assessment of the active substance sedaxane
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CSAA798670  very high 
(KFoc = 0.3-6.1 mL/g) 
FOCUS: yes, 0.1 µg/L 
exceeded in 4 out 9 
scenarios (max 0.318 
µg/L in Jokioinen scenario 
with FOCUS PELMO) 
 
No 
Rat acute oral LD50 > 
2000 mg/kg bw 
Negative  in vitro 
genotoxicity (3 studies) 
Rat 28-day dietary 
NOAEL = 1007 mg/kg 
bw per day 
Low risk identified. 
No toxicity data for 
aquatic organisms was 
available for this 
metabolite and therefore 
the risk assessment 
assumed that the 
metabolite was 10 times 
more toxic that the parent: 
fish chronic NOEC = 16.5 
µg/L (regulatory 
concentration including a 
safety factor of 10 = 1.65 
µg a.s./L). The risk to 
aquatic organisms was 
assessed as low. Peer Review of the pesticide risk assessment of the active substance sedaxane
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CSCD465008  very high 
(KFoc = 0.7-3.7 mL/g) 
FOCUS: yes, 0.75 µg/L 
exceeded in all 9 scenarios 
(max 6.4 µg/L in 
Jokioinen scenario with 
FOCUS PELMO) 
 
No 
Rat acute oral LD50 > 
2000 mg/kg bw 
Negative  in vitro 
genotoxicity (3 studies) 
Rat 28-day dietary 
NOAEL = 1018 mg/kg 
bw per day 
Rabbit developmental 
toxicity NOAEL = 300 
mg/kg bw per day
9 
ADI = 0.3 mg/kg bw per 
day 
Low risk identified. 
Lowest endpoint driving 
the aquatic risk 
assessment for this 
metabolite: fish acute 
LC50 > 100000 µg/L 
(regulatory concentration 
including a safety factor 
of 100 is > 1000 µg 
a.s./L). The risk to aquatic 
organisms was assessed as 
low. 
CSCD728931  no data  data gap to address the 
leaching potential  -  No data, data may be 
needed. 
No data, data may be 
needed. 
 
6.3.  Surface water and sediment 
Compound 
(name and/or code)  Ecotoxicology 
sedaxane 
Low risk identified. 
Lowest endpoint driving the aquatic risk assessment for sedaxane: fish chronic NOEC = 165 µg/L (regulatory 
concentration including a safety factor of 10 = 16.5 µg a.s./L). The risk to aquatic organisms was assessed as low. 
                                                      
9 Study presented in the dossier of two other active substances (fluxapyroxad and isopyrazam) showing a more critical outcome (Schneider et al, 2009). Peer Review of the pesticide risk assessment of the active substance sedaxane
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CSAA798670 
Low risk identified. 
No toxicity data for aquatic organisms was available for this metabolite and therefore the risk assessment assumed 
that the metabolite was 10 times more toxic that the parent: fish chronic NOEC = 16.5 µg/L (regulatory 
concentration including a safety factor of 10 = 1.65 µg a.s./L). The risk to aquatic organisms was assessed as low. 
CSCD465008 
Low risk identified. 
Lowest endpoint driving the aquatic risk assessment for this metabolite: fish acute LC50 > 100000 µg/L (regulatory 
concentration including a safety factor of 100 is > 1000 µg a.s./L). The risk to aquatic organisms was assessed as 
low. 
CSCD668095 (aqueous photolysis metabolite) 
Low risk identified. 
No toxicity data for aquatic organisms was available for this metabolite and therefore the risk assessment assumed 
that the metabolite was 10 times more toxic that the parent: fish chronic NOEC = 16.5 µg/L (regulatory 
concentration including a safety factor of 10 = 1.65 µg a.s./L). The risk to aquatic organisms was assessed as low 
CSCD668094 (aqueous photolysis metabolite) 
Low risk identified. 
No toxicity data for aquatic organisms was available for this metabolite and therefore the risk assessment assumed 
that the metabolite was 10 times more toxic that the parent: fish chronic NOEC = 16.5 µg/L (regulatory 
concentration including a safety factor of 10 = 1.65 µg a.s./L). The risk to aquatic organisms was assessed as low 
 
6.4.  Air 
Compound 
(name and/or code)  Toxicology 
sedaxane  Rat LC50 inhalation > 5.25 mg/L air (4h, nose-only); no classification required 
 Peer Review of the pesticide risk assessment of the active substance sedaxane
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7.  List of studies to be generated, still ongoing or available but not peer reviewed 
This is a complete list of the data gaps identified during the peer review process, including those areas 
where a study may have been made available during the peer review process but not considered for 
procedural reasons (without prejudice to the provisions of Article 7 of Directive 91/414/EEC 
concerning information on potentially harmful effects). 
  Groundwater exposure assessment for the minor non-transient metabolite CSCD728931 (relevant 
for all representative uses evaluated; submission date proposed by the applicant: unknown; see 
section 4). 
  Information on the preferential metabolism/degradation in the environment of each enantiomer of 
metabolite CSCD728931 (relevant for all representative uses evaluated; submission date proposed 
by the applicant: unknown; see section 4).   
  Further data to address the long-term risk to granivorous birds (relevant for all representative uses 
evaluated, submission date proposed by the applicant: unknown; see section 5). 
  Data to support the long-term risk assessment for granivorous mammals (relevant for all 
representative uses evaluated, submission date proposed by the applicant: unknown; see section 
5). 
8.  Particular conditions proposed to be taken into account to manage the risk(s) identified 
  It should be noted that the persistent foam of the representative formulation after 1 minute is 
higher than the acceptable limit. 
9.  Concerns 
9.1.  Issues that could not be finalised 
An issue is listed as an issue that could not be finalised where there is not enough information 
available to perform an assessment, even at the lowest tier level, for the representative uses in line with 
the Uniform Principles of Annex VI to Directive 91/414/EEC and where the issue is of such 
importance that it could, when finalised, become a concern (which would also be listed as a critical 
area of concern if it is of relevance to all representative uses). 
1.  Groundwater exposure assessment for the minor non-transient metabolite CSCD728931. 
9.2.  Critical areas of concern 
An issue is listed as a critical area of concern where there is enough information available to perform 
an assessment for the representative uses in line with the Uniform Principles of Annex VI to Directive 
91/414/EEC, and where this assessment does not permit to conclude that for at least one of the 
representative uses it may be expected that a plant protection product containing the active substance 
will not have any harmful effect on human or animal health or on groundwater or any unacceptable 
influence on the environment.   
An issue is also listed as a critical area of concern where the assessment at a higher tier level could not 
be finalised due to a lack of information, and where the assessment performed at the lower tier level 
does not permit to conclude that for at least one of the representative uses it may be expected that a 
plant protection product containing the active substance will not have any harmful effect on human or 
animal health or on groundwater or any unacceptable influence on the environment. Peer Review of the pesticide risk assessment of the active substance sedaxane
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2.  On the basis of the available data, a high long-term risk was identified for granivorous birds and 
granivorous mammals. Peer Review of the pesticide risk assessment of the active substance sedaxane
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9.3.  Overview of the assessments for each representative use considered 
(If a particular condition proposed to be taken into account to manage an identified risk, as listed in 
section 8, has been evaluated as being effective, then ‘risk identified’ is not indicated in this table.) 
Representative use  Wheat (seed treatment) 
Operator risk 
Risk identified   
Assessment not finalised   
Worker risk 
Risk identified   
Assessment not finalised   
Bystander risk 
Risk identified   
Assessment not finalised   
Consumer risk 
Risk identified   
Assessment not finalised   
Risk to wild non 
target terrestrial 
vertebrates 
Risk identified  X
2 
Assessment not finalised 
 
Risk to wild non 
target terrestrial 
organisms other 
than vertebrates 
Risk identified   
Assessment not finalised 
 
Risk to aquatic 
organisms 
Risk identified   
Assessment not finalised 
Groundwater 
exposure active 
substance 
Legal parametric value 
breached   
Assessment not finalised   
Groundwater 
exposure 
metabolites 
Legal parametric value 
breached   
Parametric value of 
10µg/L
(a) breached   
Assessment not finalised  X
1
Comments/Remarks   
The superscript numbers in this table relate to the numbered points indicated as concerns indicated in sections 9.1 and 9.2.  
Where there is no superscript number see sections 2 to 6 for further information. 
(a):  Value for non-relevant metabolites prescribed in SANCO/221/2000-rev 10-final, European Commission, 2003 
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APPENDICES 
APPENDIX  A – LIST OF END POINTS FOR THE ACTIVE SUBSTANCE AND THE REPRESENTATIVE 
FORMULATION 
 
Identity, Physical and Chemical Properties, Details of Uses, Further Information 
 
Active substance (ISO Common Name) ‡  Sedaxane 
Function (e.g. fungicide)  Fungicide for Seed Treatment 
 
Rapporteur Member State  France 
Co-rapporteur Member State  - 
 
Identity (Annex IIA, point 1) 
 
Chemical name (IUPAC) ‡  mixture of 2 cis-isomers 2′-[(1RS,2RS)-1,1′-bicycloprop-
2-yl]-3-(difluoromethyl)-1-methylpyrazole-4-
carboxanilide and 2 trans-isomers 2′-[(1RS,2SR)-1,1′-
bicycloprop-2-yl]-3-(difluoromethyl)-1-methylpyrazole-
4-carboxanilide 
Chemical name (CA) ‡  N-[2-[1,1′-bicyclopropyl]-2-ylphenyl]-3-
(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide 
CIPAC No ‡  833 
CAS No ‡  874967-67-6 
(trans isomer: 599197-38-3 / cis isomer: 599194-51-1) 
EC No (EINECS or ELINCS) ‡  Not available 
FAO Specification (including year of publication) ‡  None 
Minimum purity of the active substance as 
manufactured ‡ 
Min. 960 g/kg Sedaxane 
(range 820-890 g/kg for the 2 trans-isomers (50:50 
mixture of enantiomers , and range 100-150 g/kg for the 2 
cis-isomers (50:50 mixture of enantiomers) 
Identity of relevant impurities (of toxicological, 
ecotoxicological and/or environmental concern) in 
the active substance as manufactured 
None 
Molecular formula ‡  C18H19F2N3O 
Molecular mass ‡  331.4 Peer Review of the pesticide risk assessment of the active substance sedaxane
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Structural formula ‡ 
N
N
F
F
H
N
O
 
Trans isomer (SYN508210) 
 
N
N
F
F
H
N
O
 
Cis isomer (SYN508211) 
 
* 
* 
* 
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Physical and chemical properties (Annex IIA, point 2) 
Melting point (state purity) ‡  121.4°C (99.6%) 
Boiling point (state purity) ‡  > 270°C (99.6%) 
Temperature of decomposition (state purity)  Decomposition beginning at 270°C (99.6%) 
Appearance (state purity) ‡  white powder (99.6%) 
grey-beige powder (technical AI, 97.5%) 
Vapour pressure (state temperature, state purity) 
‡ 
6.5 x 10
-8 Pa (20°C) 
1.7 x10
-7 Pa (25°C) 
Henry’s law constant ‡  4.0 x 10
-6   Pa m³/mol (25°C) 
Solubility in water (state temperature, state 
purity and pH) ‡ 
14 mg/l (25°C) 
Solubility in organic solvents ‡ 
(state temperature, state purity) 
Acetone:              410 g/L (25°C)  
Dichloromethane:            500 g/L (25°C)  
Ethyl acetate:              200 g/L (25°C)  
Hexane:                           410 mg/L (25°C)  
Methanol:              110 g/L (25°C) 
Octanol:                           20 g/L (25°C)  
Toluene:                            70 g/L (25°C) 
Surface tension ‡ 
(state concentration and temperature, state 
purity) 
48.6 mN/m at 20°C (90% saturated aqueous solution) 
Partition co-efficient ‡ 
(state temperature, pH and purity) 
Log Pow= 3.3 (25°C) (99.6%) 
(pH not relevant as the active substance shows no pH 
dependency) 
Dissociation constant (state purity) ‡  No pKa found in the range of 1.0 to 12.0 by spectro-
photometric titration of a solution in water (99.6%) 
UV/VIS absorption (max.) incl.  ‡  
(state purity, pH) 
Solution wavelength  molar extinction coefficient 
        [nm]               [l/mol x cm] 
_________________________________________________
_ 
Neutral      225    17233 
     265        5996 
      295          874 
Acidic      225    17423 
     265        5683 
      295          851 
Basic      225    17393 
     265        5833 
      295          955 
No absorption maximum after 340 nm was observed (99.6%) 
Flammability ‡ (state purity)  Not highly flammable (97.5%) 
Not auto-flammable (97.5%) 
Explosive properties ‡ (state purity)  No explosive properties (97.5%) Peer Review of the pesticide risk assessment of the active substance sedaxane
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Oxidising properties ‡ (state purity)  No oxidising properties (97.5%) 
 Peer Review of the pesticide risk assessment of the active substance sedaxane
 
EFSA Journal 2012;10(7):2823    28
 
Summary of representative uses evaluated (name of active substance or the respective variant)* 
 
Crop 
and/or 
situation 
(a) 
Member 
State 
Product 
Name 
F 
G 
I 
(b) 
Pests or group 
of pests 
controlled 
(c) 
Formulation Application  Application rate per treatment 
PHI 
(days) 
(l) 
Remarks 
(m)  Type 
(d-f) 
Conc of 
a.s. g/L 
(i) 
Method 
kind 
(f-h) 
Growth 
stage and 
season 
(j) 
Number 
min max 
(k) 
Interval 
between 
applications
(min) 
g a.i./100 
kg seed  
min max 
Slurry 
volume 
(ml/100 kg 
seed)  
min max 
G a.i./ha 
min max 
(*) 
(g/ha) 
Wheat FR  A16148C F  Microdochium 
Nivale 
FS 500  Seed 
treatment 
NA  1  NA  10  400 ml – 
1200 ml (20 
ml 
A16148C/d
t + 380-
1180 ml 
water/dt) 
25 NA  Sowing 
rate: max. 
250 kg 
seeds/ha 
 
*  For uses where the column „Remarks“ in marked in grey further consideration is necessary. Uses 
should be crossed out when the notifier no longer supports this use(s). 
(a)  For crops, the EU and Codex classification (both) should be taken into account ; where relevant, the 
use situation should be described (e.g. fumigation of a structure) 
(b)  Outdoor or field use (F), greenhouse application (G) or indoor application (I) 
(c)  e.g. biting and suckling insects, soil born insects, foliar fungi, weeds 
(d)  e.g. wettable powder (WP), emulsifiable concentrate (EC), granule (GR) 
(e)  GCPF Codes – GIFAP Technical Monograph N° 2, 1989 
(f)  All abbreviations used must be explained 
(g)  Method, e.g. high volume spraying, low volume spraying, spreading, dusting, drench 
(h)  Kind, e.g. overall, broadcast, aerial spraying, row, individual plant, between the plant – type of 
equipment used must be indicated 
(i)  g/kg or g/L. Normally the rate should be given for the active substance (according to ISO) and not 
for the variant in order to compare the rate for same active substances used in different variants (e.g. 
fluoroxypyr). In certain cases, where only one variant synthesised, it is more appropriate to give 
the rate for the variant (e.g. benthiavalicarb-isopropyl). 
(j)  Growth stage at last treatment (BBCH Monograph, Growth Stages of Plants, 1997, Blackwell, ISBN 
3-8263-3152-4), including where relevant, information on season at time of application 
(k)  Indicate the minimum and maximum number of application possible under practical conditions of use 
(l)  The values should be given in g or kg whatever gives the more manageable number (e.g. 200 kg/ha 
instead of 200 000 g/ha or 12.5 g/ha instead of 0.0125 kg/ha 
(m)  PHI - minimum pre-harvest interval 
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Methods of Analysis 
Analytical methods for the active substance (Annex IIA, point 4.1) 
 
Technical as (analytical technique)  HPLC-UV  
Impurities in technical as (analytical technique)  Confidential, see Document J 
HPLC-UV and GC-FID (impurity identity confirmed with 
mass spectroscopy) 
Plant protection product (analytical technique)  HPLC-UV 
 
 
Analytical methods for residues (Annex IIA, point 4.2) 
Residue definitions for monitoring purposes 
 
Food of plant origin  Sedaxane (sum of SYN508210 and SYN508211) 
Food of animal origin  Sedaxane (sum of SYN508210 and SYN508211) 
Soil  Sedaxane (sum of SYN508210 and SYN508211) 
Water   surface  Sedaxane (sum of SYN508210 and SYN508211) 
 drinking/ground  Sedaxane  (sum  of SYN508210 and SYN508211) and  
Metabolite CSCD465008 and Metabolite CSAA798670 
Air  Sedaxane (sum of SYN508210 and SYN508211) 
 
Monitoring/Enforcement methods 
 
Food/feed of plant origin (analytical technique and 
LOQ for methods for monitoring purposes) 
HPLC-MS/MS 
wheat grain, wheat straw, wheat whole plant, carrot, 
spinach, potato, whole orange, oilseed rape, lentils and 
tomato 
LOQ:  0.005 mg/kg for SYN508210 
              0.005 mg/kg for SYN508211 
Soybean seed: 
LOQ:    0.01 mg/kg for metabolite CSCD465008 
Food/feed of animal origin (analytical technique and 
LOQ for methods for monitoring purposes) 
HPLC-MS/MS 
Bovine meat, fat, kidney, liver, milk and eggs:  
LOQ:  0.005 mg/kg for SYN508210 
              0.005 mg/kg for SYN508211 
              0.01 mg/kg for metabolite CSCD658906 
              0.01 mg/kg for metabolite CSCD659087 
Soil (analytical technique and LOQ)  HPLC-MS/MS Peer Review of the pesticide risk assessment of the active substance sedaxane
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LOQ:  0.0001 mg/kg for SYN508210 
              0.0001 mg/kg for SYN508211 
              0.0001 mg/kg for metabolite CSCC210616 
              0.0005 mg/kg for metabolite CSCD465008 
              0.0005 mg/kg for metabolite CSAA798670 
Water (analytical technique and LOQ)  HPLC-MS/MS 
Drinking water, ground water and surface water: 
LOQ:  0.05 µg/L for SYN508210 
              0.05 µg/L for SYN508211 
              0.05 µg/L for metabolite CSCC210616 
              0.05 µg/L for metabolite CSCD465008 
              0.05 µg/L for metabolite CSAA798670 
Air (analytical technique and LOQ)  HPLC-MS/MS 
LOQ: 0.375  µg/m
3 for SYN508210 
              0.375 µg/m
3 for SYN508211 
 
Body fluids and tissues (analytical technique and 
LOQ) 
HPLC-MS/MS 
Bovine blood 
LOQ:  0.005 mg/kg for SYN508210 
              0.005 mg/kg for SYN508211  
 
Classification and proposed labelling with regard to physical and chemical data (Annex IIA, 
point 10) 
  RMS/peer review proposal 
Active substance  - 
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Impact on Human and Animal Health 
Absorption, distribution, excretion and metabolism (toxicokinetics) (Annex IIA, point 5.1) 
Rate and extent of oral absorption ‡  87-89 % based on urine and bile excretion, carcass and 
cage wash residues within 48 h  
Tmax value 1-1.5h  
Distribution ‡  Widely distributed 
Potential for accumulation ‡  No evidence of accumulation 
Rate and extent of excretion ‡  Rapid excretion mainly via faeces 
Urinary (11.8-17.2 % within 72h) 
faeces (72-83 % within 72h)  
Bile (78-81 % in 48 hours) 
T½: 22-24h 
Metabolism in animals ‡  Extensive metabolism in rat: demethylation, 
hydroxylation, oxidation and subsequent conjugation. 
Toxicologically relevant compounds ‡ 
(animals and plants) 
Sedaxane 
Toxicologically relevant compounds ‡ 
(environment) 
Sedaxane 
 
 
Acute toxicity (Annex IIA, point 5.2) 
Rat LD50 oral ‡  Between 2000 - 5000 mg/kg bw   
Rat LD50 dermal ‡  > 5000 mg/kg bw   
Rat LC50 inhalation ‡  > 5.25 mg/L air (4h, nose-only)   
Skin irritation ‡  Non irritant   
Eye irritation ‡  Non irritant   
Skin sensitisation ‡  Non sensitizer (LLNA)   
 
 
Short-term toxicity (Annex IIA, point 5.3) 
Target / critical effect ‡  Reduced body weight and body weight gain (all species) 
Rats: Liver (increased weight), reduced foregrip strengh 
(females)  
Mice: Testis and liver (increase adjusted weight) 
Dogs: clinical biochemistry parameters, liver (increased 
weight) 
Relevant oral NOAEL ‡  90-day rat: 28 mg/kg bw per day  
90-day & 1-year dog: 50 mg/kg bw per day  
90-day mice: 567 mg/kg bw per day  
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Relevant dermal NOAEL ‡  28-day rat: 1000 mg/kg bw per day (limit 
dose) 
 
Relevant inhalation NOAEL ‡  No data - not required   
 
 
Genotoxicity ‡ (Annex IIA, point 5.4) 
  Sedaxane is unlikely to be genotoxic   
 
 
Long-term toxicity and carcinogenicity (Annex IIA, point 5.5) 
Target/critical effect ‡  Liver ( hypertrophy, increased weight )/ thyroid follicular 
cell hypertrophy, basophilia (rat) 
Increased incidence of hepatic adenoma and carcinoma at 
high dose (mouse) 
Relevant NOAEL ‡  11 mg/kg bw per day; 2-year rat 
157 mg/kg bw per day; 18-month mouse 
Carcinogenicity ‡  Overall no clear carcinogenic potential: 
Carcinogenic effects observed at high dose 
level in male mice (liver tumours) 
considered non-relevant to humans 
Carcinogenic NOAEL: 157 mg/kg per day 
(male mice) 
No carcinogenic effect in rats up to 218 
mg/kg bw per day, the highest dose tested 
 
 
 
Reproductive toxicity (Annex IIA, point 5.6) 
Reproduction toxicity 
Reproduction target / critical effect ‡  Parental: reduced body weight, body weight 
gain and food consumption, liver 
(hypertrophy and increased weight). 
Reproductive: No effect on fertility 
Offspring: reduced body weight, increased 
liver weight and increased anogenital 
distance in F2 pups 
 
Relevant parental NOAEL ‡  35 mg/kg bw per day    
Relevant reproductive NOAEL ‡  104 mg/kg bw per day    
Relevant offspring NOAEL ‡  35 mg/kg bw per day    Peer Review of the pesticide risk assessment of the active substance sedaxane
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Developmental toxicity 
Developmental target / critical effect ‡  Rats:  
Maternal: Reduced food consumption and 
body weight gain 
Development: No effect 
Rabbit:  
Maternal: Reduced food consumption, body 
weight gain (or body weight loss) and liver 
(increased weight) 
Development: decreased foetal weight  
 
Relevant maternal NOAEL ‡  Rat: 25 mg/kg bw per day 
Rabbit: 100 mg/kg bw per day 
 
Relevant developmental NOAEL ‡  Rat: 200 mg/kg bw per day 
Rabbit: 100 mg/kg/bw per day 
 
 
 
Neurotoxicity (Annex IIA, point 5.7) 
Acute neurotoxicity ‡  No evidence of neurotoxicity 
NOAEL (general toxicity): 30 mg/kg bw 
based on reduced locomotor activity, 
decreased body weight, body weight gain, 
food consumption. 
 
Repeated neurotoxicity ‡  90-day, rat: No evidence of neurotoxicity 
NOAEL: 66 mg/kg bw per day based on 
body weight decrease, reduced locomotor 
activity  
 
Delayed neurotoxicity ‡  No data-not required   
 
 
Other toxicological studies (Annex IIA, point 5.8) 
Mechanism studies ‡  Rat 28-day dietary – comparative study trans vs cis 
isomer: 
SYN508210 (trans-isomers), SYN508211 (cis-isomers) 
and a 1:1 mixture of the two isomers caused the same 
qualitative effects and overall, there was very little 
difference in the incidence or severity of findings 
between the three test compounds. 
All three test materials produced similar histopathological 
changes in the liver (centrilobular hypertrophy) with no 
evidence of cytotoxicity.  Liver biochemistry 
measurements indicated CYP2B and CYP3A induction 
with all three compounds. Peer Review of the pesticide risk assessment of the active substance sedaxane
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Studies performed on metabolites or impurities ‡ 
 
Metabolite CSCD465008 
Rat oral LD50 > 2000 mg/kg bw 
In vitro genotoxicity: negative in bacterial reverse 
mutation, cytogenetics and mammalian cell gene mutation 
tests 
28-day rat: NOAEL 1018 mg/kg bw per day (the highest 
dose tested) 
Rabbit developmental toxicity
10: maternal NOAEL 300 
mg/kg bw per day. Effects at maternal LOAEL: ↓ 
bodyweight, ↓ food consumption, ↑abortion incidence, 
(considered to be a secondary non-specific consequence 
of maternal toxicity) and developmental NOAEL 1000 
mg/kg bw per day (the highest dose tested) 
ADI 0.3 mg/kg bw per day based on the developmental 
toxicity study, SF 1000 
 
Metabolite CSAA798670 
Rat oral LD50 > 2000 mg/kg bw 
In vitro genotoxicity: negative in bacterial reverse 
mutation, chromosome aberration, mammalian gene cell 
mutation, chromosome aberration tests 
28-day rat: NOAEL 1007 mg/kg bw per day (the highest 
dose tested) 
 
 
Medical data ‡ (Annex IIA, point 5.9) 
  No adverse health effects reported 
 
 
Summary (Annex IIA, point 5.10)  Value Study  Safety  factor 
ADI ‡  0.11 mg/kg bw per 
day  
rat, 2-year 
study 
100 
AOEL ‡  0.28 mg/kg bw per 
day  
rat, 90-day 
study  
100* 
ARfD ‡  0.3 mg/kg bw  rat, acute 
neurotoxicity 
study 
100 
* No correction required regarding oral absorption 
 
Dermal absorption ‡ (Annex IIIA, point 7.3) 
Formulation (A16148C 500 g/L FS)  Concentrate: 0.01 % 
Spray dilution 1/20: 0.16 % rounded to 0.2 %  
                                                      
10 Study presented in another dossier (fluxapyroxad and isopyrazam) showing more critical effects. Peer Review of the pesticide risk assessment of the active substance sedaxane
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Spray dilution 1/200: 0.12 % rounded to 0.2 %  
Rat in vivo and comparative in vitro (human/rat skin)  
 
 
Exposure scenarios (Annex IIIA, point 7.2) 
Operator  Seed treatment - French seed Tropex model 
Seed treatment: 10 % of the AOEL (without PPE) 
Workers  Sowing of seeds treated - French seed Tropex model 
Sowing: 1.6 % of the AOEL (PPE: long sleeved work 
jacket and long trousers) 
Bystanders  Not relevant for a seed treatment use 
 
 
Classification and proposed labelling with regard to toxicological data (Annex IIA, point 10) 
  RMS/peer review proposal 
sedaxane none 
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Metabolism in plants (Annex IIA, point 6.1 and 6.7, Annex IIIA, point 8.1 and 8.6) 
 
Plant  groups  covered  Cereals (spring wheat), Pulses and oilseeds (soybean), 
Leafy crops (Swiss chard) – seed treatment. 
Rotational crops  Cereals (wheat), Root vegetables (radish, turnip), Leafy 
crops (lettuce) – Application to bare soil or as a seed 
treatment. 
Metabolism in rotational crops similar to 
metabolism in primary crops? 
Yes 
Processed commodities  Processed cereal commodities (cleaned grain, pot barley, 
bran, barley flour). 
Residue pattern in processed commodities similar to 
residue pattern in raw commodities? 
Yes – Sedaxane is stable under the representative 
conditions of processing such as pasteurisation, 
baking/brewing/boiling and sterilisation. 
Plant residue definition for monitoring  Sedaxane (SYN524464) (sum of isomers) 
(restricted to seed and soil treatments) 
Plant residue definition for risk assessment  Sedaxane (SYN524464) (sum of isomers) 
(restricted to seed and soil treatments) 
Conversion factor (monitoring to risk assessment)  - 
 
Metabolism in livestock (Annex IIA, point 6.2 and 6.7, Annex IIIA, point 8.1 and 8.6) 
 
Animals covered  Laying hens, lactating goats 
Time needed to reach a plateau concentration in 
milk and eggs 
Eggs : approximately 9 days 
Milk : approximately 2 days 
Animal residue definition for monitoring  Sedaxane (SYN524464) (sum of isomers) 
Animal residue definition for risk assessment  Sedaxane (SYN524464) (sum of isomers) 
Conversion factor (monitoring to risk assessment)  - 
Metabolism in rat and ruminant similar (yes/no)  Yes 
Fat soluble residue: (yes/no)  No 
 
Residues in succeeding crops (Annex IIA, point 6.6, Annex IIIA, point 8.5) 
 
 
 
 
 
 
Residue trials (carrot/radish, spinach, wheat/barley) 
conducted at 0.9 N considering the calculated plateau 
concentration of sedaxane in soil (section 4): 
-Sedaxane (trans-SYN508210 and cis-SYN508211): 
Residues <LOQ (0.005 mg/kg for each isomer) in edible 
parts of rotated crops 
-Metabolites CSAA798670, CSCD465008 and other 
metabolites:  
Residues <LOQ (0.01 mg/kg) in edible parts of rotated Peer Review of the pesticide risk assessment of the active substance sedaxane
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crops. 
 
Stability of residues (Annex IIA, point 6 introduction, Annex IIIA, point 8 Introduction) 
 
  Sedaxane (SYN508210 and SYN508211), 
CSCD465008, other metabolites 
Stable at <-18°C in high water, high acid, high oil content 
and dry commodities (24 months).  
CSAA798670 
Stable at <-18°C in high water content and dry 
commodities (12 months)  
 
Storage stability data cover the storage time interval of 
the residue samples from the residue trials on cereals, the 
rotational crop field trials and the processed commodities.
 
Residues from livestock feeding studies (Annex IIA, point 6.4, Annex IIIA, point 8.3) 
 
  Ruminant Poultry  Pig 
  Conditions of requirement of feeding studies 
Expected intakes by livestock  0.1 mg/kg diet (dry 
weight basis) (yes/no - If yes, specify the level) 
No No  No 
Potential for accumulation (yes/no) N/A  N/A  N/A 
Metabolism studies indicate potential level of 
residues ≥ 0.01 mg/kg in edible tissues (yes/no) 
N/A N/A  N/A 
  Feeding studies (Specify the feeding rate in cattle and 
poultry studies considered as relevant) 
Residue levels in matrices : Mean (max) mg/kg 
Feeding rate   2.2 mg/kg diet (DM basis) 
Muscle  Sedaxane: <0.01 
CSCD659087: <0.01 
CSCD658906: <0.01 
N/A N/A 
Liver  Sedaxane: <0.01 
CSCD659087: <0.01 
CSCD658906: 0.03 
N/A N/A 
Kidney  Sedaxane: <0.01 
CSCD659087: <0.01 
CSCD658906: 0.02 
N/A N/A 
Fat  Sedaxane: <0.01 
CSCD659087: <0.01 
CSCD658906: <0.01 
N/A N/A Peer Review of the pesticide risk assessment of the active substance sedaxane
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Milk  Sedaxane: <0.01 
CSCD659087: <0.01 
CSCD658906: <0.01 
   
Eggs   N/A   
 
N/A: Not applicable 
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Summary of residues data according to the representative use on wheat (Annex IIA, point 6.3, Annex IIIA, point 8.2) 
 
Crop 
Northern/ 
Southern 
Region, 
field or 
glasshouse 
Trials results relevant to the 
representative uses 
(a) 
Recommendation/ comments 
MRL 
estimated from 
trials according 
to representative 
use (mg/kg) 
HR 
(mg/kg) 
(c) 
STMR 
(mg/kg) 
 
(b) 
Wheat  N-EU  Grain :  13x <0.01 
Straw :  13x<0.01 
Residues of Sedaxane (Sum Trans-SYN508210 and 
Cis-SYN508211 isomers) 
 
0.01* <0.01   
 
<0.01  
 
S-EU  Grain :  10x <0.01 
Straw :  8x <0.01; 0.011; 0.012 
(a) Numbers of trials in which particular residue levels were reported e.g. 3x <0.01, 0.01, 6x 0.02, 0.04, 0.08, 2x 0.1, 2x 0.15, 1x 0.17 
(b) Supervised Trials Median Residue i.e. the median residue level estimated on the basis of supervised trials relating to the representative use 
(c) Highest residue 
 
 
MRL application according to Commission Regulation (EU) No 188/2011 (Article 3,(1) (g)) 
 
Summary of residues data provided in the framework of the MRL application under Commission Regulation (EU) No 188/2011 (Article 3,(1) (g)) 
 
Crop 
Northern/ 
Southern 
Region, 
field or 
glasshouse 
Trials results relevant to the 
representative uses 
(a) 
Recommendation/ comments 
MRL 
estimated from 
trials according 
to representative 
use (mg/kg) 
HR 
(mg/kg) 
(c) 
STMR 
(mg/kg) 
 
(b) 
Barley, oat, 
rye, triticale 
N-EU 
S-EU 
-  Extrapolation from EU residue database on wheat  0.01*  -  - 
Soybean  USA  Seed :  2x <0.01  Trials performed as a seed treatment at 120 g/100 kg seed  0.01*   <0.01   <0.01  
Brazil  Seed :  2x <0.01 Peer Review of the pesticide risk assessment of the active substance sedaxane
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Rapeseed 
(Canola)
  
USA  Seed :  8x <0.01  Trials performed as a seed treatment at 7.5 g/100 kg seed  0.01*   <0.01   <0.01  
Canada  Seed :  16x <0.01  Trials performed as a seed treatment at 5.87 g/100 kg seed 
 (a) Numbers of trials in which particular residue levels were reported e.g. 3x <0.01, 0.01, 6x 0.02, 0.04, 0.08, 2x 0.1, 2x 0.15, 1x 0.17 
(b) Supervised Trials Median Residue i.e. the median residue level estimated on the basis of supervised trials relating to the representative use 
(c) Highest residue Peer Review of the pesticide risk assessment of the active substance sedaxane
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Consumer risk assessment (Annex IIA, point 6.9, Annex IIIA, point 8.8) 
 
ADI  0.11 mg/kg bw per day 
TMDI (% ADI) according to EFSA PRIMo Model  <1% ADI 
IEDI (WHO European Diet) % ADI)  N/A 
NEDI (specify diet) (% ADI)  N/A 
Factors included in IEDI and NEDI  N/A 
ARfD  0.3 mg/kg bw 
IESTI (%ARfD)  <1% ARfD 
NESTI (% ARfD) according to national (to be 
specified) large portion consumption data 
N/A 
Factors included in IESTI and NESTI  N/A 
 
Processing factors (Annex IIA, point 6.5, Annex IIIA, point 8.4) 
 
Processing factors could not be calculated as no residues were observed above the limit of quantification of 0.01 
mg/kg (sum of SYN508210 and SYN508211) in any pre-processing and processed samples. 
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Considering the MRL proposal on barley, oat, rye, triticale, soybean and rapeseed, the intakes by animals remain 
by far below the trigger value of 0.1 mg/kg diet (DM) and therefore, the setting of MRLs for products of animal 
origin was considered unnecessary. 
 
Taking into account the overall MRL on cereals and import tolerances of 0.01* mg/kg proposed for soybean and 
rapeseed and using the EFSA PRIMo model, no chronic or acute risk was identified for consumers, the highest 
TMDI and highest IESTI remaining below 1% of the ADI and ARfD respectively. 
 
Proposed MRLs (Annex IIA, point 6.7, Annex IIIA, point 8.6) 
 
Wheat (representative use):   0.01*mg/kg 
 
 
MRL proposal on barley, oat, rye and triticale the 
requested import tolerances evaluated in the frame 
of the MRL setting procedure 
Barley, oat, rye, triticale: 0.01* mg/kg (by extrapolation 
from wheat) 
Rapeseed : 0.01*mg/kg  
Soybean : 0.01*mg/kg  
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Route of degradation (aerobic) in soil (Annex IIA, point 7.1.1.1.1) 
 
Mineralization after 100 days ‡  0.6% - 20.1% of applied radioactivity in 7 soils at 122-
123 DAT (pyrazole and phenyl labels). 
Non-extractable residues after 100 days ‡  3 studies; 7 soils; after 122-123 DAT: 17.2-40.4% 
(pyrazole and phenyl labels). 
Metabolites requiring further consideration ‡ 
- name and/or code, % of applied (range and 
maximum) 
CSCD465008: maximum 31.9% at 237 DAT % (max 
range 13.5-31.9%); seed applied. 
CSAA798670: maximum 14.5% at 367 DAT % (max 
range 0.8-6.1%); soil applied. 
CSCD728931: maximum 6.3 % at 241 DAT (minor non 
transient metabolite); soil applied. 
A data gap for information on the environmental 
behaviour of each individual enantiomer of metabolite 
CSCD728931 in soil was identified. 
Many other unidentified transformation products, all <5%
 
Route of degradation in soil - Supplemental studies (Annex IIA, point 7.1.1.1.2) 
 
Anaerobic degradation ‡   
Mineralization after 100 days  4.2% CO2 at 62 days  
Non-extractable residues after 100 days  30.6% un-extracted residues at 90 days 
Metabolites that may require further consideration 
for risk assessment – name and/or code, % of 
applied (range and maximum) 
Not observed 
(phenyl label) 
Soil photolysis ‡   
Metabolites that may require further consideration 
for risk assessment – name and/or code, % of 
applied (range and maximum) 
DT50: 105 - 230 days of summer sunlight (calculated for a 
latitude of 30°N).   
Products formed: all transformation products <5% and 
low levels of mineralisation (
14CO2 1.5 %) 
 
Rate of degradation in soil (Annex IIA, point 7.1.1.2, Annex IIIA, point 9.1.1) 
 
Laboratory studies ‡  
 
Parent  Aerobic conditions (seed applied)- Modelling endpoints 
Soil type  X  pH 
(CaCl2) 
t. °C / % 
MWHC  DT50/DT90 (d) 
DT50 (d)  
20°C 
pF2/10kPa 
Chi
2 
error 
Method of  
calculation 
Loam (a) 
(Gartenacker) 
 6.9  20°C/pF2 
66.4
(1)/ 216 
(59.4; 65.49
(2); 
75.1/ 197; 205; 
250) 
65.1  
 
5.2; 
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Sandy clay 
loam (a) 
(North 
Dakota)  
 6.7  20°C/pF2 
68.4
(1) /227 
(76.5; 61.1/254; 
203) 
68.4 
 
15.8/11.
2  SFO 
Sand (b) 
(California) 
 
 7.9  20°C/pF2  1000*/1000  1000*  6.4 
DFOP* 
(k1 = 
0.0512, k2 
= 2.310
-14, 
g = 0.6544)
18 Acres (c) 
Sandy Clay 
Loam 
 5.8  20°C/pF2  90.7/301 90.7  8.7  SFO 
Silty Clay (c) 
Marsillargues 
 
 7.5  20°C/pF2  52.4/174 52.4  9.3  SFO 
Pappelacker 
(c) 
Loamy Sand 
 6.9  20°C/pF2  74.2/247 74.2  5.6  SFO 
Geometric  mean/median 20°C/pF2  108  108    
a pyrazole and phenyl labels 
b Pyrazole label 
c Phenyl label 
(1) Geometric means of the DT50 for the same soils ; numbers below are the detailed values. 
*SFO kinetics did not describe the degradation kinetics adequately therefore the slow phase degradation was 
used from DFOP kinetics. 
(2) For one of the Gartenacker soil, incubation was conducted at 20
oC but with a slightly sub-optimal soil 
moisture content of 32.0%w/w compared to a measured pF2 of 34.8%w/w (Hand and Khawaja, 2008). A 
correction factor of 0.943 was applied for this soil, resulting in a normalised DT50 of 61.8 days.  
 
Parent  Aerobic conditions (seed applied)- Persistence endpoints 
Soil type  X  pH 
(CaCl2) 
t. °C / % 
MWHC  DT50/DT90 
DT50  
20°C 
pF2/10kPa 
Chi
2 
error 
Method of 
calculation 
Loam (a) 
(Gartenacker) 
 6.9  20°C/pF2 
63.4
(1) 
/ >1000 
(59.4; 65.5
(2); 
65.6/ 197; 218; 
292) 
62.2 
 
5.2; 
8.9;8.9 
SFO; SFO; 
DFOP* (k1 = 
0.1826, k2 = 
0.0071, g = 
0.2025) 
Sandy clay 
loam (a) 
(North 
Dakota)  
 6.7  20°C/pF2 
43.7
(1) />1000 
(48.5; 
39.4/>1000; 
>1000) 
43.7  11.1; 
4.5 
FOMC (alpha 
= 0.3256, beta 
= 6.5447); 
DFOP* (k1 = 
0.0371, k2 = 
5.1e-014, g = 
0.6507) 
Sand (b) 
(California) 
 
  7.9  20°C/pF2  28.2 / >1000  28.2  6.4 
DFOP* (k1 = 
0.0512, k2 = 
2.310
-14, g = 
0.6544) Peer Review of the pesticide risk assessment of the active substance sedaxane
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18 Acres (c)  
Sandy Clay 
Loam 
  5.8  20°C/pF2  69.0 / >1000  69.0  1.3 
DFOP (k1 = 
0.0404, k2 = 
9.4e-004, g = 
0.4993) 
Silty Clay (c) 
Marsillargues 
 
  7.5  20°C/pF2  38.8 / >1000  38.8  5.6 
DFOP (k1 = 
0.03, k2 = 
2.3e-008, g = 
0.7274) 
Pappelacker 
(c) 
Loamy Sand 
  6.9  20°C/pF2  68.3 / 471  68.3  5.4 
FOMC (alpha 
= 1.3074, beta 
= 97.6376) 
a pyrazole and phenyl labels 
b Pyrazole label 
c Phenyl label 
(1) Geometric means of the DT50 for the same soils; numbers below are the detailed values. 
*SFO kinetics did not describe the degradation kinetics adequately therefore the slow phase degradation was 
used from DFOP kinetics. 
(2) For one of the Gartenacker soil, incubation was conducted at 20
oC but with a slightly sub-optimal soil 
moisture content of 32.0%w/w compared to a measured pF2 of 34.8%w/w (Hand and Khawaja, 2008). A 
correction factor of 0.943 was applied for this soil, resulting in a normalised DT50 of 61.8 days.  
 
 
Parent  Aerobic conditions (soil applied) – Not used in the risk assessment for the representative use as 
seed treatment. 
Soil type  label
  pH 
(CaCl2) 
t. 
oC / % 
MWHC 
DT50 /DT90 
(d)  
DT50 (d) 
20C 
pF2/10kPa 
Chi
2 error  Method of 
calculation 
Loam 
(Gartenacker) 
Pyrazol
e  6.9 20°C/pF2 
296/983 296
  13.1 SFO 
Sand 
(California) 
Pyrazol
e 
7.9  20°C/pF2  342.8/>100
0 
342.8 8.3  SFO 
Sandy clay loam 
(North Dakota)  
Pyrazol
e 
6.7  20°C/pF2  376.9/>100
0 
376.9 13.4  SFO 
Sandy clay loam 
(North Dakota)  
Phenyl 6.7  20°C/pF2  421.8/>100
0 
421.8 8.4  SFO 
 geometric  mean  356.4   
 
 
CSAA798670  Aerobic conditions (from the soil degradation study (Simmonds & MacKenzie, 2009) where soils were dosed with 
the minor soil metabolite CSCC210616 (precursor of metabolite CSAA798670)) 
Soil type  X
1 
pH 
(Ca
Cl2) 
t. °C / % 
MWHC 
DT50/DT90 
(d) 
f. f. 
*kdp/kf 
DT50 (d) 
20°C 
pF2/10kPa 
St. (r
2)  Method of 
circulation 
Sandy Clay 
Loam (18 
Acres) 
13 6.4  20°C/pF2  6.2/20  1.000  -  6.2 0.99  SFO 
Loam 
(Gartenacker)  37 7.1 20°C/pF2  3.2/11  0.961  -  3.2 0.98  SFO 
Silty Clay  22 7.7 20°C/pF2  18/59  1.000  -  18 0.98  SFO Peer Review of the pesticide risk assessment of the active substance sedaxane
 
EFSA Journal 2012;10(7):2823    46
(Marsillargues) 
Sandy clay 
loam 
(North Dakota) 
11 6.7 20°C/pF2  13/44  0.967  -  13 0.98  SFO 
Geometric mean/median      0.982  8.3    -   
* from CSCC210616  
 
 
CSCD465008 Aerobic  conditions 
Soil type  X
1 
pH 
(Ca
Cl2) 
t. °C / % 
MWHC 
DT50/DT90 
(d) 
f. f. 
**kdp/kf 
DT50 (d) 
20°C 
pF2/10kPa 
Chi
2 error  Method of 
circulation 
-  Sand
y Clay Loam 
(18 Acres) 
  5.8-
6.5  20°C/pF2 
70.8* 
(112; 78.9; 
40.1/372; 
262; 134) 
-  0
.696  -  70.8  4.7; 6.7; 
6.4  SFO 
-  Loam 
(Gartenacker)    6.9-
7.2  20°C/pF2 
100.1* 
(78.8; 129; 
98.7/262; 
427; 328) 
-  0
.960  -  100  5.8; 1.6;5.8  SFO 
-  Silty 
Clay 
(Marsillargues) 
  7.5-
7.8  20°C/pF2 
165.5* 
(152; 190; 
157/505; 
631; 521) 
-  0
.848  -  166  17; 1.5; 
0.71  SFO 
Sandy clay 
loam 
-  (Nort
h Dakota) 
 6.7  20°C/pF2  142/472 
-  0
.773  -  142  6.5 SFO 
Geometric mean/median    114  0.82  114    -   
* Geometric mean of the DT50s for the same soils ; numbers in brackets below are the detailed DT50/DT90 values. The first value is 
derived from the soil degradation study (Simmonds & MacKenzie, 2009) where 4 soils were dosed with the minor soil metabolite 
CSCC210616 (precursor of metabolite CSAA798670); the other two values are derived from the studies (Kuet and Oliver, 2007 and Volkel, 
2008) where metabolite CSCD465008 was applied to three soils as parent compound. 
**from CSAA798670 
 
Field studies ‡ 
Parent Aerobic  conditions 
Soil type  Location  X
1 pH  Depth 
(cm) 
DT50 
(d) 
actual 
DT90 
(d) 
actual 
Chi
2 
error
b) 
DT50 
(d) 
Norm
a) 
Method of 
circulatio
n 
-  Silt 
loam 
-  France 
(North)   -   7.7 0-10  125 413  16.2 
71.7 
SFO 
-  Silt 
loam 
-  France 
(South)   -   8.2 0-20  158 521  18.4 
54.6 
SFO 
-  Loam
y sand  -  Italy   -  6.9 0-20  129 428  12.7 
135 
SFO 
-  Silty 
clay loam 
-  German
y   -   8.3 0-10 
438 
(worst 
case 
value) 
>1000  7.8 
188 
SFO 
Geometric mean/median        100  -   Peer Review of the pesticide risk assessment of the active substance sedaxane
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a)  Normalised using a Q10 of 2.58 and Walker equation coefficient of 0.7 
b)  Statistic tests of the kinetic modelling evaluation of data normalised to 20ºC (timestep normalisation) 
 
 
As in the field studies the application rates were (range 9.9-16 g a.i./ha) than the dose (25 g a.i./ha) indicated in 
the GAP table, it can be concluded that these field trials might be considered as not suitable to provide accurate 
information on the soil degradation products formed under field conditions.  
 
 
pH dependence ‡ 
(yes / no) (if yes type of dependence) 
no 
Soil accumulation and plateau concentration ‡  No evidence for accumulation of sedaxane over a two 
year period. 
Plateau concentration 0.0433 mg/kg  in 5cm associated 
with max. concentration of  0.076  mg/kg  , based on 
worst-case DT50f (438 days) and 25 g/ha application, 
reached after 14 years 
As in the field studies the application rates were (6.7 and 
18.04 g a.i./ha) than the dose (25 g a.i./ha) indicated in 
the GAP table, it can be concluded that these field trials 
might be considered as not suitable to provide accurate 
information on the soil degradation products formed 
under field conditions.  
 
Laboratory studies ‡ 
Parent Anaerobic  conditions 
Soil type  X
2 
pH 
(cacl2
) 
t. °C / % MWHC  DT50/DT90 (d) 
DT50 (d) 
20°C 
pF2/10kPa 
St. (r
2)  Method of 
circulation 
Silt Loam 
(Gartenacker)   7.1  20/75%pF2  374.4*/  374.4  0.798  SFO 
Geometric mean/median      -     
*Extrapolated beyond study duration 
Under anaerobic conditions, sedaxane degraded to five degradates by HPLC, none of which exceeded 5.2% AR 
 
 
Soil adsorption/desorption (Annex IIA, point 7.1.2) 
 
Parent ‡ 
Soil type  OC %  Soil pH 
(CaCl2)  Kd (mL/g)  Koc 
(mL/g) 
Kf 
(mL/g) 
Kfoc 
(mL/g)  1/n 
Loam (Gartenacker)   2.60 6.8 na  na  6.82  262  0.81 
Silty Clay 
(Marsillargues)   1.04  7.5  na  na  5.72 548 0.86 
Sandy Clay (Loam 
18 Acres)  
2.78  5.1 na  na  16.74  602 0.91 
Sandy Loam 
(Visalia)  
0.52 5.7 na  na  3.06  588  0.91 
Silty Clay 
(Champaign)  
2.44  7.1 na  na  13.13  538  0.84 
Sand  (Washington)  0.32  7.0  na  na  2.00  666  0.86 Peer Review of the pesticide risk assessment of the active substance sedaxane
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Arithmetic mean/median  7.9/6.3  534/568  0.87/0.8
6 
pH dependence, Yes or No  no 
 
Metabolite 1 : CSAA798670 
Soil type  OC %  Soil pH 
(CaCl2)  Kd (mL/g) Koc 
(mL/g)  Kf (mL/g)  Kfoc 
(mL/g)  1/n 
Loam (Gartenacker)   2.1 6.1  -  na -  na 0.04 2.1 0.94 
Sandy clay loam (18 Acres)   2.5 7.2  na  na  0.07  2.7  0.85 
Silty clay (Marsillargues)   0.7 7.6  na  na  0.02  3.6  1.02 
Sandy loam (North Dakota)   3.9 6.8  -  na -  na 0.01 0.3 0.78 
Loamy sand (California)   0.4 6.8  na  na  0.02  6.1  0.93 
Arithmetic mean/median  0.032/0.0
2  3/2.7 0.9/0.93 
pH dependence, Yes or No  no 
 
Metabolite 2 : CSCD465008 
Soil type  OC %  Soil pH 
(KCl)  Kd (mL/g) Koc 
(mL/g) 
Kf 
(mL/g) 
Kfoc 
(mL/g)  1/n 
Loam (Gartenacker)   2.1 6.9  -  na -  na 0.02 0.71 0.67 
Sandy clay loam (18 Acres)   2.8 5.3  na  na  0.10  3.7  0.98 
Silty clay (Marsillargues)   1 7.5  na  na  0.02  1.9  0.9 
Arithmetic mean/median  0.05/0.0
2  2.1/1.9 0.85/0.9 
pH dependence, Yes or No  no 
 
 
Mobility in soil (Annex IIA, point 7.1.3, Annex IIIA, point 9.1.2) 
 
Column leaching ‡  Study  not conducted as reliable adsorption coefficient 
values available from the adsorption/desorption studies 
Aged residues leaching ‡  Study not conducted as reliable adsorption coefficient 
values available from the adsorption/desorption studies 
 
Lysimeter/ field leaching studies ‡  Study  not conducted as reliable adsorption coefficient 
values available from the adsorption/desorption studies 
 
PEC (soil) (Annex IIIA, point 9.1.3) 
 
Parent : sedaxane 
Method of calculation 
DT50 (d): 438 days (field, worst case value)  
SFO kinetics 
Application data  Crop: cereals (seed treatment) 
Depth of soil layer: 5 cm Peer Review of the pesticide risk assessment of the active substance sedaxane
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Soil bulk density: 1.5 g/cm3 
% plant interception: na 
Number of application: 1  
Interval (d): na 
Application rate(s): 25 g a.s./ha  
 
PEC(s) 
(mg/kg) 
Single application 
Actual 
Single application 
Time weighted 
average 
Multiple application 
Actual 
Multiple application 
Time weighted 
average 
Initial 0.0333   NA   
Short-term  24h  0.0333 0.0333    
2d  0.0332 0.0333 NA  NA 
4d  0.0331 0.0332    
Long-term 7d  -  0.0330 -  0.0331    
28d  -  0.0319 -  0.0326  NA NA 
50d  -  0.0308 -  0.320    
100d  0.0285 0.0308   
Plateau 
concentration 
0.0433 after 14years 
(max.PEC : 0.076) 
   
Table 1:   NA – Not Applicable (only a single application) 
 
 
 
Metabolite I : CSAA798670 
Method of calculation 
Molecular mass: 176.1g/mole 
Application data  Maximum concentration : 14.5% (soil applied) 
 
PEC(s) 
(mg/kg) 
Single application 
Actual 
Single application 
Time weighted 
average 
Multiple application 
Actual 
Multiple application 
Time weighted 
average 
Initial 0.0026   NA   
Short-term 24h  nc*  nc*     
2d nc  nc  NA  NA 
4d nc  nc     
Long-term 7d  nc  nc     
28d nc  nc  NA  NA 
50d nc  nc     
100d nc  nc     
Plateau 
concentration 
NA      
*nc: not calculated, further risk assessment relies on initial PECsoil  
Table 2:   NA – Not Applicable (only a single application) 
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Metabolite II: CSCD465008 
Method of calculation 
Molecular mass: 162.1 g/mol 
Application data  Maximum concentration : 31.9% 
 
PEC(s) 
(mg/kg) 
Single application 
Actual 
Single application 
Time weighted 
average 
Multiple application 
Actual 
Multiple application 
Time weighted 
average 
Initial 0.00519*   NA   
Short-term 24h  nc*  nc*     
2d nc  nc  NA  NA 
4d nc  nc     
Long-term 7d  nc  nc     
28d nc  nc  NA  NA 
50d nc  nc     
100d nc  nc     
Plateau 
concentration 
NA      
*further risk assessment relies on initial PECsoil  
Table 3:   NA – Not Applicable (only a single application) 
 
Route and rate of degradation in water (Annex IIA, point 7.2.1) 
 
Hydrolytic degradation of the active substance and 
metabolites > 10 % ‡ 
Stable at pH 4, 5, 7 and 9 at 50ºC. 
DT50 > 1 year 
Photolytic degradation of active substance and 
metabolites above 10 % ‡ 
DT50 (in sterile pH7 buffer – direct photolysis) 42-72 
days Summer Sunlight Equivalents (30º-50ºN).  
Three photodegredates: CSCD668094 (maximum 5%), 
CSCD668095 (maximum 6%) and CSAA798670 
(maximum 12%)  
DT50 (in sterile natural water – indirect photolysis) 16-
17 days Summer Sunlight Equivalents (30º-50ºN).  
Three photodegredates: CSCD668094 (maximum 15%), 
CSCD668095 (maximum 16%) and CSAA798670 
(maximum 26%) 
Quantum yield of direct phototransformation in 
water at  > 290 nm 
0.0277 molecules degraded/photon 
Readily biodegradable ‡  
(yes/no) 
No 
 
Degradation in water / sediment 
Parent  Distribution (41.4 in water after 7d.;  Max. sed 88.4% after 70 d) 
Water / 
sediment 
pH 
water 
pH 
sed 
(CaC
t. 
oC 
DT50- 
whole sys. 
χ
2 
DT50-DT90 
water 
χ
2 
DT50- 
sed 
χ
2 
Method 
of 
calculatPeer Review of the pesticide risk assessment of the active substance sedaxane
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system phase  l2)  ion 
Möhlin 
(sandy 
loam,  
River) 
7.7 7.4  201  847 1.5
13.5 (HS 
DT90/3.32) -
44.8 
HS 
parameters 
0.2658;0.036
0;3) 
1.0 847 1.5  HS 
Rothenfluh 
(Silt loam , 
Pond) 
7.4 7.2  201  885 2.1
22.2 (FOMC 
DT90/3.32) -
74 
1.1 885 2.1  FOMC
                    
Geometric mean/median    866   17.3-58  866   
 
 
Mineralization and non extractable residues 
Water / sediment 
system 
pH 
water 
phase 
pH sed 
(CaCl2) 
Mineralization 
x % after n d. (end of 
the study) 
Non-extractable 
residues in sed. max x % 
after n d 
Non-extractable 
residues in sed. max x 
% after n d (end of 
the study) 
Möhlin (sandy 
loam,  River)  7.7  7.4  2% after 179 days  12.6% after 179 days 
(end of the study)  12.6% after 179 days 
Rothenfluh (Silt 
loam , Pond)  7.4  7.2  1.8% after 179 days  11.5% after 179 days 
(end of the study) 
11.5% after 179 days 
(end of the study) 
 
PEC (surface water) and PEC sediment (Annex IIIA, point 9.2.3) 
 
Parent sedaxane 
Parameters used in FOCUSsw step 1 and 2 
FOCUS calculator : FOCUS Step 1-2 version 1.1 
Molecular weight (g/mol): 331 
Water solubility at 20°C (mg/L): 14 
KfOC (L/kg): 534 
DT50 soil (d): 100 (step2) 
DT50 water/sediment system (d): 866 
DT50 water (d): 866 (step2) 
DT50 sediment (d): 866 (step2) 
Crop interception (%): no drift (incorp or seed trtmt) 
Parameters used in FOCUSsw step 3 (if performed)  No used for risk assessment  
Application rate  25g as/ha 
Main routes of entry  Drainage and Runoff  
 
FOCUS STEP 1 
Scenario 
Day after overall 
maximum 
PECSW (µg/L) PECSED (µg/kg) 
Actual TWA  Actual    TWA 
 
0 h  4.87   26   
24 h  4.86  4.87  26  26 
2 d  4.96  4.86  26  26 
4  d  4.85 4.86 25.9 26 Peer Review of the pesticide risk assessment of the active substance sedaxane
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7  d  4.84 4.85 25.8 25.9 
14  d 4.81 4.84 25.7 25.9 
21  d 4.79 4.83 25.6 25.8 
28  d 4.79 4.81 25.4 25.7 
42 d  4.7  4.79  25.1  25.6 
 
 
FOCUS STEP 2 
Scenario 
Spring Cereals 
Day after overall 
maximum 
PECSW (µg/L) PECSED (µg/kg) 
Actual TWA  Actual    TWA 
Northern EU 
March-May 
0 h  0.95   5.06   
24  h 0.95 0.95 5.05 5.05 
2  d  0.95 0.95 5.05 5.05 
4  d  0.94 0.95 5.04 5.05 
7  d  0.94 0.94 5.03 5.04 
14  d 0.94 0.94 5.00 5.03 
21  d 0.93 0.94 4.97 5.01 
28  d 0.93 0.94 4.94 5.00 
42  d 0.92 0.93 4.89 4.97 
Southern EU 
March-May 
0 h  1.89   10.11   
24  h 1.89 1.89 10.10  10.11 
2  d  1.89 1.89 10.10  10.10 
4  d  1.89 1.89 10.08  10.10 
7  d  1.88 1.89 10.06  10.09 
14  d 1.87 1.88 10.00  10.06 
21  d 1.86 1.88 9.94 10.03 
28  d 1.85 1.87 9.89 10.00 
42  d 1.83 1.86 9.78 9.94 
 
 
FOCUS STEP 2 
Scenario 
Winter Cereals 
 
Day after overall 
maximum 
PECSW (µg/L) PECSED (µg/kg) 
Actual TWA  Actual    TWA 
Northern EU 
Oct-Feb 
0 h  2.37  --- 12.64  --- 
24  h 2.37 2.37 12.63  12.64 
2  d  2.36 2.37 12.62  12.63 
4  d  2.36 2.36 12.60  12.62 
7  d  2.35 2.36 12.57  12.61 Peer Review of the pesticide risk assessment of the active substance sedaxane
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14  d 2.34 2.35 12.50  12.57 
21  d 2.33 2.35 12.43  12.54 
28  d 2.31 2.34 12.36  12.50 
42  d 2.29 2.33 12.22  12.43 
Southern EU 
Oct-Feb 
0 h  1.89  --- 10.11  --- 
24  h 1.89 1.89 10.10  10.11 
2  d  1.89 1.89 10.10  10.10 
4  d  1.89 1.89 10.08  10.10 
7  d  1.88 1.89 10.06  10.08 
14  d 1.87 1.88 10.00  10.06 
21  d 1.86 1.88 9.94 10.03 
28  d 1.85 1.87 9.89 10.00 
42  d 1.83 1.86 9.78 9.94 
 
Metabolite CSAA798670 
Parameters used in FOCUSsw step 1 and 2 
Molecular weight (g/mol): 176 
Water solubility at 20°C (mg/L): 100(a) 
KfOC (L/kg): 3 
DT50 soil (d): 8.3 (step2) 
Maximum in soil (%) : 14.5 (soil applied) 
Maximum in water/sediment (%) : 25.7 (maximum 
observed in indirect aqueous photolysis study) 
DT50 water/sediment system (d): 1000 (a) 
Parameters used in FOCUSsw step 3 (if performed)  no 
Application rate  - 
Main routes of entry  Drainage and runoff 
(a)  Default value 
 
 
FOCUS STEP 1 
Scenario 
Day after overall 
maximum 
PECSW (µg/L) PECSED (µg/kg) 
Actual TWA  Actual    TWA 
 
0 h  0.64   0.02   
24  h  nc nc nc nc 
2  d  nc nc nc nc 
4  d  nc nc nc nc 
7  d  nc nc nc nc 
14  d  nc nc nc nc 
21  d  nc nc nc nc 
28  d  nc nc nc nc 
42  d  nc nc nc nc 
 
nc – Not Calculated 
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Scenario 
Winter Cereals 
 
maximum 
Actual TWA  Actual    TWA 
Northern EU 
Oct-Feb 
0 h  0.23  --- 0.007  --- 
24  h  nc nc nc nc 
2  d  nc nc nc nc 
4  d  nc nc nc nc 
7  d  nc nc nc nc 
14  d  nc nc nc nc 
21  d  nc nc nc nc 
28  d  nc nc nc nc 
42  d  nc nc nc nc 
nc – Not Calculated 
 
Metabolite CSCD465008 
Parameters used in FOCUSsw step 1 and 2 
Molecular weight (g/mol): 162 
Water solubility at 20°C (mg/L): 100(a) 
KfOC (L/kg): 2.1 
DT50 soil (d): 114 (step2) 
Maximum in soil (%) : 31.9 (seed applied) 
Maximum in water/sediment (%) : 0  
DT50 water/sediment system (d): 1000 (a) 
Parameters used in FOCUSsw step 3 (if performed)  no 
Application rate  - 
Main routes of entry  Drainage and runoff 
(a)  Default value 
 
 
FOCUS STEP 1 
Scenario 
Day after overall 
maximum 
PECSW (µg/L) PECSED (µg/kg) 
Actual TWA  Actual    TWA 
 
0 h  1.30   0.027   
24 h  1.30  1.30  0.027  0.027 
2 d  1.30  1.30  0.027  0.027 
4 d  1.29  1.30  0.027  0.027 
7 d  1.29  1.30  0.027  0.027 
14 d  1.29  1.29  0.027  0.027 
21 d  1.28  1.29  0.027  0.027 
28 d  1.27  1.29  0.027  0.027 
42 d  1.26  1.28  0.027  0.027 
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Metabolite CSCD668095 
Parameters used in FOCUSsw step 1 and 2 
Molecular weight (g/mol): 339 
Water solubility at 20°C (mg/L): 100(a) 
KfOC (L/kg): 0/10000(b) 
DT50 soil (d): 1000 (a) 
Maximum in soil (%) : 0 
Maximum in water/sediment (%) : 15.8 (photolysis)  
DT50 water/sediment system (d): 1000 (a) 
Parameters used in FOCUSsw step 3 (if performed)  no 
Application rate  - 
Main routes of entry  Drainage and runoff 
(a)  Default value 
(b) 
b KFoc 0 assumed for PECsw and 10000 for PECsed calculations 
 
 
 
FOCUS STEP 1 
Scenario 
Day after overall 
maximum 
PECSW (µg/L) PECSED (µg/kg) 
Actual TWA  Actual    TWA 
 
0 h  0.79   5.25   
24  h  nc nc nc nc 
2  d  nc nc nc nc 
4  d  nc nc nc nc 
7  d  nc nc nc nc 
14  d  nc nc nc nc 
21  d  nc nc nc nc 
28  d  nc nc nc nc 
42  d  nc nc nc nc 
 
FOCUS STEP 2 
Scenario 
Day after overall 
maximum 
PECSW (µg/L) PECSED (µg/kg) 
Actual TWA  Actual    TWA 
 
0 h  0.38   2.87   
24  h  nc nc nc nc 
2  d  nc nc nc nc 
4  d  nc nc nc nc 
7  d  nc nc nc nc 
14  d  nc nc nc nc 
21  d  nc nc nc nc 
28  d  nc nc nc nc 
42  d  nc nc nc nc 
 
Metabolite CSCD668094 
Parameters used in FOCUSsw step 1 and 2 
Molecular weight (g/mol): 365 
Water solubility at 20°C (mg/L): 100(a) 
KfOC (L/kg): 0/10000 (b) 
DT50 soil (d): 1000 (a) 
Maximum in soil (%) : 0 
Maximum in water/sediment (%) : 15.8 (photolysis)  
DT50 water/sediment system (d): 1000 (a) 
Parameters used in FOCUSsw step 3 (if performed)  no 
Application rate  - Peer Review of the pesticide risk assessment of the active substance sedaxane
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Main routes of entry  Drainage and runoff 
(a)  Default value 
(b) 
b KFoc 0 assumed for PECsw and 10000 for PECsed calculations 
 
 
 
FOCUS STEP 1 
Scenario 
Day after overall 
maximum 
PECSW (µg/L) PECSED (µg/kg) 
Actual TWA  Actual    TWA 
 
0 h  0.79   5.65   
24  h  nc nc nc nc 
2  d  nc nc nc nc 
4  d  nc nc nc nc 
7  d  nc nc nc nc 
14  d  nc nc nc nc 
21  d  nc nc nc nc 
28  d  nc nc nc nc 
42  d  nc nc nc nc 
 
FOCUS STEP 2 
Scenario 
Day after overall 
maximum 
PECSW (µg/L) PECSED (µg/kg) 
Actual TWA  Actual    TWA 
 
0 h  0.39   0.39   
24  h  nc nc nc nc 
2  d  nc nc nc nc 
4  d  nc nc nc nc 
7  d  nc nc nc nc 
14  d  nc nc nc nc 
21  d  nc nc nc nc 
28  d  nc nc nc nc 
42  d  nc nc nc nc 
 
PEC (ground water) (Annex IIIA, point 9.2.1) 
 
Method of calculation and type of study (e.g. 
modelling, field leaching, lysimeter ) 
FOCUS Groundwater Modelling  ; FOCUS Pelmo 3.3.2 and 
FOCUS PEARL3-3-3 
Application rate  Winter and spring cereals, seed treatment, 25 g ai/ha 
Sedaxane: Molecular weight (g/mol): 331 
Water solubility at 20°C (mg/L): 14 
Saturated Vapour Pressure at 20°C (Pa): 0 (set to 0, field 
degradation data used for Sedaxane) 
KfOC (L/kg): 534 (average, n=5) 
Freundlich exponent (1/n): 0.865 (average, n=5) 
DT50 soil (d): 100 (geomean normalised field n=4) 
Q10: 2.58 
Plant uptake factor : 0(conservative) 
Crop interception (%): seed treatment 
Saturated Vapour Pressure at 20°C (Pa): 0 
CSAA798670 : Molecular weight (g/mol): 176 
Water solubility at 20°C (mg/L): 100(default) 
KfOC (L/kg): 3 (average, n=4) Peer Review of the pesticide risk assessment of the active substance sedaxane
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Freundlich exponent (1/n): 0.91 (average, n=4) 
DT50 soil (d): 8.3 (lab, geomean n=4) 
Q10: 2.58 
Ffm:1 (from parent) 
 
CSCD465008 Molecular weight (g/mol): 162 
Water solubility at 20°C (mg/L): 100(default) 
Saturated Vapour Pressure at 20°C (Pa): 0 
KfOC (L/kg): 2.1 (average, n=4) 
Freundlich exponent (1/n): 0.85 (average, n=4 3) 
DT50 soil (d): 114 (lab, geomean n=4) 
Q10:2.2 2.58 
Ffm:1 from CSAA798670  
 
Application parameters for winter and spring cereals 
Scenario Application 
dates 
Emergence 
(FOCUS) 
 Winte
r 
Sprin
g 
Winte
r 
Sprin
g 
-  Châteaudun  16
th 
Oct 
28
th 
Feb 
26
th 
Oct 
10
th 
March 
-  Hamburg  22
nd 
Oct 
22
nd 
March 
1
st 
Nov 
1
st 
May 
-  Jokioinen  10
th 
sept 
8
th 
May 
20
th 
sept 
18
th 
May 
-  Kremsmünster  26
th 
Oct 
22
nd 
March 
5
th 
Nov 
1
st 
May 
-  Okehampton  7
th Oct  22
nd 
March 
17
th 
Oct 
1
st 
May 
-  Piacenza  21
st 
Nov 
- 1
st 
Dec 
- 
-  Porto  20
th 
Nov 
28
th 
Feb 
30
th 
Nov 
10
th 
March 
-  Sevilla  20
th 
Nov 
- 30
th 
Nov 
- 
Thiva 20
th 
Nov 
- 30
th 
Nov 
- 
 
PEC (gw) – FOCUS modelling result (80
th percentile annual average concentration at 1m) 
Spring cereals 
F
O
C
U
S
 
P
e
l
m
o
 
3
.
3
.
2
/
S
p
r
i
n
g
 
c
e
r
e
a
l
s
 
(
s
e
e
d
 
t
r
e
a
t
m
e
n
t
)
 
Scenario Parent  (µg/L) 
Metabolite (µg/L) 
CSAA798670 CSCD465008 
Chateaudun  -  <0.001  0.007 3.160 
Hamburg  -  <0.001  0.129 4.426 
Jokioinen  -  <0.001  0.214 5.985 
Kremsmunster  -  <0.001  0.023 4.087 
Okehampton  -  <0.001  0.062 2.566 
Piacenza  -  --  - - 
Porto  -  <0.001  -  0.012 -  1.547 
Sevilla  -  --  -  - -  - 
Thiva  -  --  -  - -  - 
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Scenario Parent  (µg/L) 
Metabolite (µg/L) 
CSAA798670 CSCD465008 
Chateaudun  -  <0.001  0.023 3.183 
Hamburg  -  <0.001  0.155 3.953 
Jokioinen  -  <0.001  0.212 5.448 
Kremsmunster  -  <0.001  0.056 2.368 
Okehampton  -  <0.001  0.087 2.154 
Piacenza  -  --  - - 
Porto  -  <0.001  -  0.018 -  1.251 
Sevilla  -  --  -  - -  - 
Thiva  -  --  -  - -  - 
 
Winter cereals 
F
O
C
U
S
 
P
e
l
m
o
 
3
.
3
.
2
/
W
i
n
t
e
r
 
c
e
r
e
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s
 
(
s
e
e
d
 
t
r
e
a
t
m
e
n
t
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Scenario Parent  (µg/L) 
Metabolite (µg/L) 
CSAA798670 CSCD465008 
Chateaudun  -  <0.001  0.023 3.542 
Hamburg  -  <0.001  0.203 3.762 
Jokioinen  -  <0.001  0.318 6.371 
Kremsmunster  -  <0.001  0.042 3.164 
Okehampton  -  <0.001  0.151 2.444 
Piacenza  -  <0.001  0.103 2.929 
Porto  -  <0.001  0.049 1.620 
Sevilla  -  <0.001  0.016 1.848 
Thiva  -  <0.001  0.019 2.666 
 
 
F
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3
.
2
/
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s
e
e
d
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m
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  Scenario Parent  (µg/L) 
Metabolite (µg/L) 
CSAA798670 CSCD465008 
Chateaudun  -  <0.001  0.036 3.682 
Hamburg  -  <0.001  0.174 3.223 
Jokioinen  -  <0.001  0.263 6.115 
Kremsmunster  -  <0.001  0.065 2.098 
Okehampton  -  <0.001  0.125 2.055 
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Porto  -  <0.001  0.031 1.299 
Sevilla  -  <0.001  0.024 1.887 
Thiva  -  <0.001  0.027 3.278 
 
 
A data gap for groundwater exposure assessment for the minor non transient metabolite CSCD728931 
was identified during the peer review of sedaxane. 
 
 
 
 
PEC (gw) From lysimeter / field studies 
 
No data provided 
 
Fate and behaviour in air (Annex IIA, point 7.2.2, Annex III, point 9.3) 
 
Direct photolysis in air ‡  Atkinson calculation:  half-life = 5.1 h 
Quantum yield of direct phototransformation  0.0277 molecules degraded/photon  
Photochemical oxidative degradation in air ‡  DT50: 5.1 hours as measured by AOP. 
Volatilisation ‡  from soil:  6.5 x 10
-08 Pa at 20ºC and 1.7 x 10
-07 Pa at 
25ºC 
from plant surfaces:  Not applicable (seed treatment) 
Henry’s law constant: 4.0 x 10
-6 Pa m³/mol (25°C) 
Metabolites No  data 
 
PEC (air) 
Method of calculation  Qualitative – Atkinson calculation for photolysis in air 
and volatility 
 
PEC (a) 
Maximum concentration  Negligible 
 
Residues requiring further assessment 
 
Environmental occurring residues requiring further 
assessment by other disciplines (toxicology and 
ecotoxicology) and or requiring consideration for 
groundwater exposure. 
Soil:  Sedaxane, CSAA798670, CSCD465008 
Surface water: Sedaxane, CSAA798670, CSCD465008, 
CSCD668094 (aqueous photolysis) and CSCD668095 
(aqueous photolysis). 
Sediment: Sedaxane 
Ground water: Sedaxane, CSAA798670, CSCD465008, 
CSCD728931 
Air: sedaxane 
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Monitoring data, if available (Annex IIA, point 7.4) 
 
Soil (indicate location and type of study)  No data 
Surface water (indicate location and type of study)  No data 
Ground water (indicate location and type of study)  No data 
Air (indicate location and type of study)  No data 
 
Points pertinent to the classification and proposed labelling with regard to fate and behaviour 
data 
 
R53 
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Some studies have been carried out with the formulation A16148F. This formulation is identical to A16148C 
with the exception that it contains a red dye which is omitted from A16148C therefore the formulations can be 
considered to be identical with respect to the potential risk to aquatic and terrestrial organisms. 
 
Effects on terrestrial vertebrates (Annex IIA, point 8.1, Annex IIIA, points 10.1 and 10.3) 
 
Species  Test substance  Time scale End point (mg a.s./kg 
bw/day)  End point (mg/kg feed) 
Bird ‡ 
Bobwhite quail  a.s. 
Acute 
LD50 
-  - 
-  > 2000  
-  3228 * 
1  
Bobwhite quail  SYN508210 
2  -  - -  > 2000 
Bobwhite quail  Preparation 
A16148F 
> 2000 mg f.p./kg bw
4 
(> 1068 mg a.s./kg bw)  
- 
Bobwhite quail  a.s.  Short-term 
LC50 
-  > 1354 *  >5620 
Mallard duck  a.s.  -  > 3121  5620 
Bobwhite quail  a.s.  Long-term 
NOEC 
-  96.3 *  1000 
Mallard duck  a.s.  -  134.9  1000 
Mammals ‡ 
Indicate species a.s. 
Acute 
LD50 
2000* - 
Rat  Preparation 
A16148F 
2975 mg f.p./kg bw 
4 
(1589 mg a.s./kg bw) 
- 
Rat a.s. 
Long-term 
NOAEL 
103.8 
3 1500 
-  *: value used for TER calculations. 
-  1: extrapolated acute toxicity value according the guidance document on Risk Assessment for Birds & Mammals on request from 
EFSA. EFSA Journal 2009 
-  2: trans isomer of sedaxane - The two isomers are considered in the specification therefore the mixture is considered as stable. 
Moreover, the toxicity studies show comparable toxicological profiles for the two isomers. None additional risk is identified by the 
presence of these two isomers to aquatic and terrestrial organisms and a new study with the other isomer or with the active substance on 
second specie is not considered as usefull. 
-  3: The daily dietary dose of 103.8 mg/kg bw/day obtained with the P males. 
-  4: f.p. = formulated product 
 
 
Toxicity/exposure ratios for terrestrial vertebrates (Annex IIIA, points 10.1 and 10.3) 
 
Cereal seed treatment – 100 mg a.s./kg seed / 25 g a.s./ha 
Indicator species/Category Time  scale  DDD/ETE  TER  Annex VI 
Trigger 
Tier 1 (Birds) 
Small granivorous bird 
(food item: seeds) 
Acute 30  108  10 
Short-term 30  >  45  10 
Long-term 30  3.2  5 Peer Review of the pesticide risk assessment of the active substance sedaxane
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Indicator species/Category Time  scale  DDD/ETE  TER  Annex VI 
Trigger 
Small omnivorous bird 
(food item: newly emerged 
shoots) 
Acute 10  323  10 
Short-term 10  >  135  10 
Long-term 10  9.6  5 
Birds via the consumption 
of contaminated water 
Acute  0.0014  2.3 x 10
6 10 
Long-term  0.0014  6.9 x 10
4 5 
earthworm-eating birds  Long-term  0.187  510  5 
fish-eating birds  Long-term  0.0366  2600  5 
Higher tier refinement (Birds) 
- -  -  -  -  
Tier 1 (Mammals) 
Small omnivorous mammal 
(food item: seeds) 
Acute 24 
83 
66 (based on the 
toxicity of the 
formulated product) 
10 
Long-term 24  4.3  5 
Small omnivorous mammal  
(food item: newly emerged 
shoots) 
Acute 4.8  417  10 
Long-term 4.8  22  5 
Mammals via the 
consumption of 
contaminated water 
Acute  0.0007  2.8 x 10
6  10 
Long-term  0.0007  1.48 x 10
5 5 
earthworm-eating 
mammals  Long-term 0.228  450  5 
fish-eating mammals  Long-term  0.033  3100  5 
Higher tier refinement (Mammals) 
- -  -  -  -  
 
Toxicity data for aquatic species (most sensitive species of each group) (Annex IIA, point 8.2, 
Annex IIIA, point 10.2) 
 
Group Test  substance 
Time scale  
(Test type) 
End point   Toxicity
1 (µg a.s./L) 
Laboratory tests ‡ 
Fish 
Oncorhynchus mykiss  a.s.  96 hr (static)  Mortality, LC50 1100  (mm) Peer Review of the pesticide risk assessment of the active substance sedaxane
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Group Test  substance 
Time scale  
(Test type) 
End point   Toxicity
1 (µg a.s./L) 
-  Cyprinus carpio  a.s.  96 hr (static)  Mortality, LC50 -   620 (mm) * 
-  Pimephales 
promelas  a.s.  96 hr (static)  Mortality, LC50 -   980 (mm) 
-  Pimephales 
promelas  a.s.  ELS 32 d (flow-
through) 
fry survival, 
NOEC  165 (mm) * 
Cyprinus carpio  Preparation 
A16148F  96 hr (static)  Mortality, LC50 
1800 µg f.p./L 
 
(820 µg a.s./L) (nom) 
2 * 
Oncorhynchus mykiss  Metabolite 
CSCD465008  96 hr (static)  Mortality, LC50  > 100000 µg metabolite/L 
(nom) * 
Aquatic invertebrate 
Daphnia magna  a.s.  48 h (static)  Mortality, EC50  6100 (mm) * 
Daphnia magna a.s.  21 d (semi-
static)  Mortality, NOEC 820 (nom) * 
Daphnia magna  Preparation 
A16148F  48 h (static)  Mortality, EC50 
16400 µg f.p./L 
 
(7480 µg a.s./L) (mm) 
2 * 
Daphnia magna  Metabolite 
CSCD465008  48 h (static)  Mortality, EC50  > 100000 µg metabolite/L  
(nom) * 
Algae 
Pseudokirchneriella 
subcapitata (Selenastrum 
capricornutum) 
a.s.  96 h (static) 
Biomass, 72/96h: 
EbC50 
Growth rate, 
72/96h: ErC50 
1900 (mm) * 
1900 (mm) * 
2800 (mm) 
3000 (mm) 
Anabaena flos-aquae  a.s.  96 h (static) 
Biomass, 72/96h: 
EbC50 
Growth rate, 
72/96h: ErC50 
Yield, 72/96h: 
EyC50 
> 6500 (mm) 
Naviculla pelliculosa  a.s.  96 h (static) 
Biomass, 72/96h: 
EbC50 
Growth rate, 
72/96h: ErC50 
Yield, 72/96h: 
EyC50 
4800 (mm) 
5300 (mm) 
8700 (mm) 
10000 (mm) 
4800 (mm) 
5700 (mm) 
Pseudokirchneriella 
subcapitata (Selenastrum 
capricornutum) 
Preparation 
A16148F  96 h (static) 
Biomass, 72/96h: 
EbC50 
 
 
Growth rate, 
72/96h: ErC50 
 
 
6600 µg f.p./L (nom)   
(3000 µg a.s./L) (nom) 
6600 µg f.p./L (nom)    
(3000 µg a.s./L) (nom)   
5700 µg f.p./L (nom)   
(2600 µg a.s./L) (nom)   
6200 µg f.p./L (nom)   
(2830 µg a.s./L) (nom)   
3600 µg f.p./L (nom)  
2 * 
(1640 µg a.s./L) (nom) 
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Group Test  substance 
Time scale  
(Test type) 
End point   Toxicity
1 (µg a.s./L) 
Yield, 72/96h: 
EyC50 
6500 µg f.p./L (nom)   
(2960 µg a.s./L) (nom)   
Pseudokirchneriella 
subcapitata (Selenastrum 
capricornutum) 
Metabolite 
CSCD465008  96 h (static) 
Biomass, 72/96h: 
EbC50 
Growth rate, 
72/96h: ErC50 
Yield, 72/96h: 
EyC50 
> 100000 µg metabolite/L 
(nom) * 
Sediment dwelling organisms - Higher plant - Microcosm or mesocosm tests 
Not required 
-  *: value used into TER calculations. 
-  1: based on nominal (nom) or mean measured concentrations (mm) 
-  2: f.p. = formulated product 
 
 
Toxicity/exposure ratios for the most sensitive aquatic organisms (Annex IIIA, point 10.2) 
 
FOCUS Step 1 
 
Cereal seed treatment – 100 mg a.s./kg seed / 25 g a.s./ha 
Test substance  Organism  Toxicity end 
point (µg/L)  Time scale  PECi (µg/L)  TER 
Annex 
VI 
Trigger 
a.s. 
Fish 620  Acute  4.87  130  100 
Fish 165  Chronic  4.87  34  10 
Aquatic invertebrates  6100  Acute  4.87  1250  100 
Aquatic invertebrates  820  Chronic  4.87  170  10 
Algae 1900  Chronic  4.87  390  10 
Metabolite 
CSCD465008 
Fish >  100000  Acute  1.30  77000  100 
Aquatic invertebrates  > 100000  Acute  1.30  77000  100 
Algae >  100000  Acute  1.30  77000  10 
Metabolite 
CSCD668094 
Fish 62
 1 Acute  0.79 78  100 
Aquatic invertebrates  610
 1 Acute  0.79  770  100 
Algae 190
 1 Acute  0.79  240  10 
Metabolite 
CSCD668095 
Fish 62
 1 Acute  0.79 78  100 
Aquatic invertebrates  610
 1 Acute  0.79  770  100 
Algae 190
 1 Acute  0.79  240  10 
Metabolite 
CSAA798670 
Fish 62
 1 Acute  0.64 97  100 
Aquatic invertebrates  610
 1 Acute  0.64  953  100 Peer Review of the pesticide risk assessment of the active substance sedaxane
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Test substance  Organism  Toxicity end 
point (µg/L)  Time scale  PECi (µg/L)  TER 
Annex 
VI 
Trigger 
Algae 190
 1 Acute  0.64  297  10 
Preparation 
A16148C 
Fish 820  Acute  4.87  170  100 
Aquatic invertebrates  7480  Acute  4.87  1530  100 
Algae 1640  Acute  4.87  340  10 
1: No studies were conducted with the metabolites CSCD668094, CSCD668095 and CSAA798670 and therefore as recommended in the 
Aquatic guidance document they are conservatively assumed to be 10 times more toxic than Sedaxane. 
 
FOCUS Step 2 
 
Cereal seed treatment – 100 mg a.s./kg seed / 25 g a.s./ha 
Test substance  Organism  Toxicity end 
point (mg/L)  Time scale  PECi TER 
Annex 
VI 
Trigger 
Metabolite CSCD668094  Fish  62
 1 Acute  0.39  160  100 
Metabolite CSCD668095  Fish  62
 1 Acute  0.38  160  100 
Metabolite CSAA798670  Fish  62
 1 Acute  0.23  270  100 
1: No studies were conducted with the metabolites CSCD668094, CSCD668095 and CSAA798670 and therefore as recommended in the 
Aquatic guidance document they are conservatively assumed to be 10 times more toxic than Sedaxane. 
 
Bioconcentration 
 Active  substance 
logPO/W 
3.3 
( Pow = 1995) 
Bioconcentration factor (BCF)
1 ‡  97 
2 
1 only required if log PO/W >3. 
2 this study was not considered as fully valid but was considered to be of sufficient quality for informative data 
(see DAR). 
 
Effects on honeybees (Annex IIA, point 8.3.1, Annex IIIA, point 10.4) 
 
Test substance  Acute oral toxicity (LD50 µg a.s./bee)  Acute contact toxicity (LD50 µg a.s./bee) 
a.s. ‡  > 4  > 100 
Preparation A16148F 
> 109.6 µg f.p. /bee
1 
(> 46.9 µg a.s./bee) 
> 100 µg f.p./bee
1 
(>  42.8 µg a.s./bee) 
Field or semi-field tests 
Not required 
-  1: f.p. = formulated product 
 
 
Hazard quotients for honey bees (Annex IIIA, point 10.4) 
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Not required for a cereal seed treatment 
 
 
Effects on other arthropod species (Annex IIA, point 8.3.2, Annex IIIA, point 10.5) 
 
Laboratory tests with standard sensitive species (glass plate studies) 
Species 
Test 
Substance 
End point 
Effect 
(LR50 g/ha – E on reproduction) 
Aphidius rhopalosiphi ‡  Preparation 
A16148F  Mortality 
LR50 = 55.8 mL f.p./ha (27.9 g a.s./ha)  
E = 14.4 % on reproduction                              
at 20 mL f.p./ha (10 g a.s./ha)
 1 
Typhlodromus pyri ‡  Preparation 
A16148F  Mortality 
LR50 > 320 mL f.p./ha (> 160 g a.s./ha) 
E = 19.4 and 17.7  % on reproduction                      
at 160 and 320 mL f.p./ha (80 and 160 g a.s./ha)
 1 
1: f.p. = formulated product 
 
Further extended laboratory studies ‡ 
Species  Life 
stage 
Test substance, 
substrate and 
duration 
Dose (g/ha)
1,2  End point  % effect
3  Trigger 
value 
Aleochara 
bilineata  Adults 
Preparation 
A16148F 
Incorporation 
into the LUFA 
2.1 sandy soil 
60 to 300 
µg/kg dry soil 
(27.4 to 137 
µg a.s./kg dry 
soil) 
E, reproduction 
(%) 
20.7, 19 and 23.2  % at 
60, 120 and 300 µg 
f.p./kg dry soil
1 (27.4, 
54.7 and 137 µg a.s./kg 
dry soil) 
50 % 
Hypoaspis 
aculeifer  Adults 
Preparation 
A16148F 
Incorporation 
into the soil (5% 
sphagnum peat) 
10 to 1000 
mg/kg dry soil 
(4.6 to 456 mg 
a.s./kg dry 
soil) 
NOEC 
 
 
E, reproduction 
(%) 
1000 mg f.p./kg dry 
soil
1 (456 mg a.s./kg 
dry soil) 
13.7  % at 1000 mg 
f.p./kg dry soil (456 mg 
a.s./kg dry soil)
 1 
50 % 
Folsomia 
candida  Adults 
-  Prepara
tion A16148F 
Incorporation 
into the soil 
(10% sphagnum 
peat) 
-  10 to 
1000 mg/kg 
dry soil (4.6 to 
456 mg a.s./kg 
dry soil) 
NOEC 
 
 
 
E, reproduction 
(%) 
1000 mg f.p./kg dry 
soil
1 (456 mg a.s./kg 
dry soil) (NOECcorr = 
500 mg f.p./kg dry soil
1 
(228 mg a.s./kg dry 
soil)) 
-  12 % at 1000 
mg f.p./kg dry soil
1 
(456 mg a.s./kg dry 
soil)
 
50 % 
1: f.p. = formulated product 
 
Field or semi-field tests 
Not required 
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Toxicity/exposure ratios for other arthropod species (Annex IIIA, point 10.5) 
 
Cereal seed treatment – 100 mg a.s./kg seed / 25 g a.s./ha  
Test substance  Species 
Effect 
(No effects on mortality or 
reproduction > 50 %) 
PECs (mg a.s./kg 
dry soil)  Low risk
 
Preparation 
A16148C  Aleochara bilineata  0.300 mg f.p./kg dry soil
 1 
(0.137 mg a.s./kg dry soil) 
-  0.076 
(plateau) 
0.033 (initial) 
Yes 
Preparation 
A16148C  Hypoaspis aculeifer  1000 mg f.p./kg dry soil 
1 (456 
mg a.s./kg dry soil) 
-  0.076 
(plateau) 
0.033 (initial) 
Yes 
Preparation 
A16148C  Folsomia candida  500 mg f.p./kg dry soil 
1 (228 
mg a.s./kg dry soil) 
-  0.076 
(plateau) 
0.033 (initial) 
Yes 
1: f.p. = formulated product 
 
 
Effects on earthworms, other soil macro-organisms and soil micro-organisms (Annex IIA points 
8.4 and 8.5. Annex IIIA, points, 10.6 and 10.7) 
 
Test organism  Test substance  Time scale  End point (mg a.s./kg d.w.soil) 
Earthworms 
Eisenia fetida a.s.  ‡  Acute 14 days, 
LC50  
-   > 1000 
(LC50 corr > 500) 
Eisenia fetida a.s.  ‡  Chronic 8 weeks, 
EC10 
2 
2.8 
(EC10 corr = 1.4)  
Eisenia fetida Preparation  A16148F 
Acute 14 days  
LC50 
-  >1000 mg f.p./kg dry soil 
-  (LC50 corr > 500 mg f.p./kg dry soil) 
1 
-  >  456 mg a.s./kg dry soil 
-  (LC50 corr  > 228 mg a.s./kg dry soil) 
 
Eisenia fetida Preparation  A16148F 
Chronic 8 weeks 
NOEC  
11.5 mg f.p./kg dry soil  
(NOEC corr = 5.75 mg f.p./kg dry soil) 
1 
5.24 mg a.s./ kg dry soil 
(NOEC corr = 2.62 mg a.s./ kg dry soil) 
Eisenia fetida Metabolite  CSCD465008 
Acute 14 days  
LC50 
> 1000 mg metabolite/kg dry soil 
Eisenia fetida Metabolite  CSCD465008 
Chronic 8 weeks  
EC10 
2 
34 mg metabolite/kg dry soil 
Other soil macro-organisms 
Hypoaspis 
aculeifer  Preparation A16148F 
Chronic 2 weeks, 
NOEC 
1000 mg f.p./kg dry soil 
1 
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Test organism  Test substance  Time scale  End point (mg a.s./kg d.w.soil) 
Collembola 
Folsomia 
candida  Preparation A16148F 
Chronic 4 weeks, 
NOEC 
-  1000 mg f.p./kg dry soil  
-  (NOEC corr = 500 mg f.p./kg dry soil) 
1 
-  456 mg a.s./kg dry soil
 
-   (NOEC corr = 228 mg a.s./kg dry soil) 
Folsomia 
candida  Metabolite CSCD465008 
Chronic 4 weeks, 
NOEC 
-  50 mg metabolite/kg dry soil 
Soil micro-organisms 
Nitrogen 
mineralisation 
a.s. ‡ 
Chronic 4 weeks, 
NOEC 
1 
Metabolite CSCD465008 
Chronic 4 weeks, 
NOEC 
0.1 mg metabolite/kg dry soil 
Carbon 
mineralisation 
a.s. ‡ 
Chronic 4 weeks, 
NOEC 
1 
Metabolite CSCD465008 
Chronic 4 weeks, 
NOEC 
0.1 mg metabolite/kg dry soil 
Field studies 
According the document SANCO 10329/2002, about litter bag study: “Testing is always required where 
contamination of soil is possible and DT90 is > 365 days”. However, when applied as A16148C, Sedaxane poses an 
acceptable risk to earthworms, Aleochara bilineata, Hypoaspis aculeifer, Folsomia candida and to soil microbial 
processes with TER values highly above the trigger values. Therefore, it is the RMS opinion that such a study is not 
deemed necessary and RMS agrees to consider Sedaxane poses an acceptable risk to organic matter breakdown when 
applied in accordance with the uses supported in this submission. 
LC50 corr and NOEC corr are due to log Pow >2.0  
1: f.p. = formulated product 
2: EC10 values presented as agreed at the Pesticide Peer Review Meeting 91 (April, 2012).  Use of EC10 values considered 
reasonable providing a sufficient margin of safety is obtained. 
 
 
Toxicity/exposure ratios for soil organisms 
 
Cereal seed treatment – 100 mg a.s./kg seed / 25 g a.s./ha  
Test organism  Test substance  Time scale  Soil PEC  TER  Trigger 
Earthworms 
Eisenia fetida a.s.  ‡  Acute 0.076
1 >  6600  10 
Eisenia fetida  a.s. ‡  Chronic   0.076
1 18  5 
Eisenia fetida Preparation  A16148C  Acute 0.076
1 >  3000  10 
Eisenia fetida  Preparation A16148C  Chronic   0.076
1 34  5 
Eisenia fetida  Metabolite CSCD465008  Acute  0.00519  > 190000  10 
Eisenia fetida Metabolite  CSCD465008  Chronic  0.00519  6500  5 
Eisenia fetida   Metabolite CSAA798670  Acute  0.0026   >192308
 2  10 
Eisenia fetida Metabolite  CSAA798670  Chronic  0.0026  538 
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Test organism  Test substance  Time scale  Soil PEC  TER  Trigger 
Other soil macro-organisms 
Hypoaspis aculeifer Preparation  A16148C  Chronic  0.076
1 6000  5 
Folsomia candida  Preparation A16148F  Chronic  0.076
1 3000  5 
Folsomia candida  Metabolite CSCD465008  Chronic  0.00519  9600  5 
Folsomia candida  Metabolite CSAA798670  Chronic  0.0026  87692 
2  5 
Hypoaspis aculeifer  Metabolite CSAA798670  Chronic  0.0026  17538 
2  5 
1: plateau PEC 
2: No toxicity data available for Metabolite CSAA798670 and therefore for the risk assessment it has been 
assumed to be 10 times more toxic than the parent. 
 
 
Effects on non target plants (Annex IIA, point 8.6, Annex IIIA, point 10.8) 
 
Laboratory dose response tests  
Most sensitive species   Test 
substance 
ER50 (g/ha) 
emergence 
Exposure 
(g/ha) 
Low risk 
Monocots: onion, oat, ryegrass, corn 
Dicots: sugarbeet, turnip, cucumber, 
soybean, lettuce, tomato 
Preparation 
A16148F 
> 219 g f.p./ha 
2 
(> 100 g a.s./ha) 
Low exposure 
as 
representative 
use is as a 
seed 
treatment
1 
Yes 
1 explanation of how exposure has been estimated should be provided (e.g. based on Ganzelmeier drift data) 
2: f.p. = formulated product 
 
 
 
Effects on biological methods for sewage treatment (Annex IIA 8.7)  
 
Test type/organism  end point 
Activated sludge  EC20 > 1000 mg a.s./L 
 
 
Ecotoxicologically relevant compounds (consider parent and all relevant metabolites requiring further 
assessment from the fate section) 
 
Compartment  
soil Sedaxane 
water Sedaxane 
sediment Sedaxane 
Ground water  Sedaxane 
 
 
Classification and proposed labelling with regard to ecotoxicological data (Annex IIA, point 10 
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  RMS/peer review proposal  
Active substance   N, R50/53 - Aquatic acute 1 / Aquatic chronic 1, H410 (P273-
P391-P501)  
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APPENDIX B – USED COMPOUND CODE(S)  
Code/Trivial name  Chemical name  Structural formula 
Trans- (SYN508210)   Trans isomer of sedaxane 
(racemate of enantiomers) 
N
N
F
F
H
N
O
 
Cis- (SYN508211)  Cis isomer of sedaxane 
(racemate of enantiomers) 
N
N
F
F
H
N
O
 
CSCD465008  3-(difluoromethyl)-1H-
pyrazole-4-carboxylic acid 
 
N-desmethyl pyrazole acid 
 
CSCD798670 
CSAA798670 
3-(difluoromethyl)-1-methyl-
1H-pyrazole-4-carboxylic 
acid 
 
Pyrazole acid 
 
CSCD728931  3-Difluoromethyl-1-methyl- 
1H-pyrazole-4-carboxylic 
acid[2-(3-cyclopropyl-1- 
hydroxy-3-oxo-propyl)- 
phenyl]-amide 
 
N
N
HF2C OH
O
CH3Peer Review of the pesticide risk assessment of the active substance sedaxane
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CSCC210616  pyrazole amide
 
CSCD668094   
N
N
CH3
HF2C NH
O
OH
OH
 
CSCD668095   
N
N
CH3
HF2C NH
O
OH
OH
O
 
CSCD658906   
N
N
HF2C NH
O
H
CH3
H
OH
 
CSCD659087   
N
H
N
HF2C NH
O
H H
OH
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ABBREVIATIONS 
1/n  slope of Freundlich isotherm 
λ wavelength 
  decadic molar extinction coefficient 
°C  degree Celsius (centigrade) 
µg microgram 
µm micrometer  (micron) 
a.s. active  substance 
AChE acetylcholinesterase 
ADE  actual dermal exposure 
ADI  acceptable daily intake 
AF assessment  factor 
AOEL  acceptable operator exposure level 
AP alkaline  phosphatase 
AR applied  radioactivity 
ARfD  acute reference dose 
AST  aspartate aminotransferase (SGOT) 
AV avoidance  factor 
BCF bioconcentration  factor 
BUN  blood urea nitrogen 
bw body  weight 
CAS  Chemical Abstracts Service 
CFU  colony forming units 
ChE cholinesterase 
CI confidence  interval 
CIPAC  Collaborative International Pesticides Analytical Council Limited 
CL confidence  limits 
cm centimetre 
Cmax  plasma peak concentration 
CYP2B  Cytochrome-P450 sub-family 2B 
CYP3A  Cytochrome-P450 sub-family 3A 
d day 
DAA  days after application 
DAR  draft assessment report 
DAT  days after treatment 
DM dry  matter 
DT50  period required for 50 percent disappearance (define method of estimation) 
DT90  period required for 90 percent disappearance (define method of estimation) 
dw dry  weight 
EbC50  effective concentration (biomass) 
EC50 effective  concentration 
ECHA  European Chemical Agency 
EEC  European Economic Community 
EINECS  European Inventory of Existing Commercial Chemical Substances 
ELINCS  European List of New Chemical Substances 
EMDI  estimated maximum daily intake 
ER50  emergence rate/effective rate, median 
ErC50  effective concentration (growth rate) 
EU European  Union 
EUROPOEM  European Predictive Operator Exposure Model 
f(twa)  time weighted average factor 
FAO  Food and Agriculture Organisation of the United Nations 
FID  Flame ionisation detector Peer Review of the pesticide risk assessment of the active substance sedaxane
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FIR  Food intake rate 
FOB  functional observation battery 
FOCUS  Forum for the Co-ordination of Pesticide Fate Models and their Use 
g gram 
GAP  good agricultural practice 
GC gas  chromatography 
GCPF  Global Crop Protection Federation (formerly known as GIFAP) 
GGT  gamma glutamyl transferase 
GM geometric  mean 
GS growth  stage 
GSH glutathion 
h hour(s) 
ha hectare 
Hb haemoglobin 
Hct haematocrit 
hL hectolitre 
HPLC  high pressure liquid chromatography  
or high performance liquid chromatography 
HPLC-MS  high pressure liquid chromatography – mass spectrometry 
HQ hazard  quotient 
IEDI  international estimated daily intake 
IESTI  international estimated short-term intake 
ISO  International Organisation for Standardisation 
IUPAC  International Union of Pure and Applied Chemistry 
JMPR  Joint Meeting on the FAO Panel of Experts on Pesticide Residues in Food and 
the Environment and the WHO Expert Group on Pesticide Residues (Joint 
Meeting on Pesticide Residues) 
Kdoc  organic carbon linear adsorption coefficient 
kg kilogram 
KFoc  Freundlich organic carbon adsorption coefficient 
L litre 
LC liquid  chromatography 
LC50  lethal concentration, median 
LC-MS  liquid chromatography-mass spectrometry 
LC-MS-MS  liquid chromatography with tandem mass spectrometry 
LD50  lethal dose, median; dosis letalis media 
LDH lactate  dehydrogenase 
LLNA  Local Lymph Node Assay 
LOAEL  lowest observable adverse effect level 
LOD  limit of detection 
LOQ  limit of quantification (determination) 
m metre 
M/L  mixing and loading 
MAF  multiple application factor 
MCH  mean corpuscular haemoglobin 
MCHC  mean corpuscular haemoglobin concentration 
MCV  mean corpuscular volume 
mg milligram 
mL millilitre 
mm millimetre 
mN milli-newton 
MRL  maximum residue limit or level 
MS mass  spectrometry 
MSDS  material safety data sheet Peer Review of the pesticide risk assessment of the active substance sedaxane
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MTD  maximum tolerated dose 
MWHC  maximum water holding capacity 
NESTI  national estimated short-term intake 
ng nanogram 
NOAEC  no observed adverse effect concentration 
NOAEL  no observed adverse effect level 
NOEC  no observed effect concentration 
NOEL  no observed effect level 
OM  organic matter content 
Pa pascal 
PD  proportion of different food types 
PEC  predicted environmental concentration 
PECair  predicted environmental concentration in air 
PECgw  predicted environmental concentration in ground water 
PECsed  predicted environmental concentration in sediment 
PECsoil  predicted environmental concentration in soil 
PECsw  predicted environmental concentration in surface water 
pH pH-value 
PHED  pesticide handler's exposure data 
PHI pre-harvest  interval 
PIE  potential inhalation exposure 
pKa  negative logarithm (to the base 10) of the dissociation constant 
Pow  partition coefficient between n-octanol and water 
PPE  personal protective equipment 
ppm  parts per million (10
-6) 
ppp  plant protection product 
PRIMo  (EFSA) Pesticide Residues Intake Model 
PT  proportion of diet obtained in the treated area 
PTT  partial thromboplastin time 
QSAR  quantitative structure-activity relationship 
r
2  coefficient of determination 
RPE  respiratory protective equipment 
RUD  residue per unit dose 
SC suspension  concentrate 
SD standard  deviation 
SFO single  first-order 
SSD  species sensitivity distribution 
STMR  supervised trials median residue 
t1/2  half-life (define method of estimation) 
TER  toxicity exposure ratio 
TERA  toxicity exposure ratio for acute exposure 
TERLT  toxicity exposure ratio following chronic exposure 
TERST  toxicity exposure ratio following repeated exposure 
TK technical  concentrate 
TLV  threshold limit value 
Tmax  time to reach plasma peak concentration (Cmax) 
TMDI  theoretical maximum daily intake 
TRR  total radioactive residue 
TSH  thyroid stimulating hormone (thyrotropin) 
TWA  time weighted average 
UDS  unscheduled DNA synthesis 
UV ultraviolet 
W/S water/sediment 
w/v  weight per volume Peer Review of the pesticide risk assessment of the active substance sedaxane
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w/w  weight per weight 
WBC  white blood cell 
WG  water dispersible granule 
WHO  World Health Organisation 
wk week 
yr year 
 